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ABSTRACT
Sansbury, Brittany Saleese. Ed.D. The University of Memphis. May 2013. Path
Analysis of Psychological Factors Associated with Medication Adherence for Individuals
with Chronic Diseases. Major Professor: Chrisann Schiro-Geist.
The 100 million U.S. residents with hypertension or diabetes generally struggle
with medication adherence (MA). On average, 65% refer to themselves as nonadherent in
some way, complicating attempts to ascertain the benefits of medical care to reduce
morbidity and mortality. It is important, therefore, to ask why patients are not taking
effective medications. In answering this question, there is some evidence that individuals
dismiss long-term benefits of better nutrition or lifestyle choices due to the asymptomatic
or silent nature of chronic diseases (Takiya, Peterson, & Finley, 2004). Nonetheless, there
has been limited progress in targeting barriers based on demographic and biomedical
factors, because they have not been modifiable predictors of adherence. Clinicians have
been looking more to internal phenomena for motivational impetus to meet treatment
demands. This community-based observational study evaluated statistical associations of
three psychological constructs, time perspective (TP), health beliefs, and health locus of
control beliefs on MA for 79 participants using data accessed with permission from the
Clinical Trial and Outcomes Branch of the National Institute of Arthritis and
Musculoskeletal and Skin Diseases. Path analysis tested the direct effect of TP on MA
and the indirect effect of TP through mediators.
Results showed that failure to complete drug regimens is a reality for over 50% of
participants. The psychological pathways exhibited some influence in observed
medication adherence, but required further manipulation to determine the model of direct
and indirect effects between variables. Most notably, analyses did not detect any direct
v

effect from either future or present-hedonistic time perspective, where older age and
greater internal locus of control directly predicted better drug use. Internal locus of
control outperformed all other predictors- an increase by a single unit contributed to a
0.77 standard deviation change in the probability of individuals having higher MA.
Among indirect effect tests, individuals' internal loci of control also mediated the effect
of time perspective on adherence. Both present-hedonistic and future outlooks operated
through the mediator to boost prescription drug use. The current study provides the first
categorical data model of the strength and direction of simultaneous associations between
the described psychological pathways and adherence.
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CHAPTER 1
Introduction
Statement of the Problem
Medication adherence (MA) is the most essential component in managing chronic
diseases (Conn et al., 2009; Kripalani, Yao, & Haynes, 2007). It can be more predictive
of successful symptom management than unalterable medical factors like disease
complexity (Mann, Ponieman, Levanthal, & Halm, 2009). Even still, only 26% of
patients comply completely with drug regimens that treat their conditions (Conn et al.,
2009). This statistic implies that a majority, or nearly 75% of all patients, contribute to a
host of preventable consequences linked to nonadherence in the United States (U.S.) including $100 billion in medical expenses, 33% of hospital or nursing home visits, and
124,000 deaths each year (Takiya, Peterson, & Finley, 2004).
The 100 million U.S. residents with hypertension or diabetes especially struggle
with MA (Broadbent, Donkin, & Stroh, 2011); on average, 65% of those with either
chronic disease admit to being nonadherent in some way (Kripalani et al., 2007;
Schimittdiel et al., 2008). The high prevalence of nonadherence complicates efforts to
ascertain the real benefits of medical care that decreases risk for stroke and other adverse
cardiovascular events (Alhalaiqa, Deane, Nawafleh, Clark, & Gray, 2012; Hashmi et al.,
2007). Consequently, it is essential for healthcare professionals to explore variables that
positively impact chronic disease treatment and mitigate financial costs and preventable
medical consequences.
One important task is to evaluate why people do not take medications that
effectively manage chronic diseases. In answering this question, contemporary literature
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says that people are less adherent to drug regimens to avoid immediate side effects like
nausea (Osterberg & Blaschke, 2005; Sluijs et al., 2006); there is also some indication
that individuals dismiss long-term benefits of better nutrition or lifestyle choices due to
the initially asymptomatic or silent nature of chronic diseases (Takiya et al., 2004).
Nonetheless, these revelations have done little to pinpoint why people perform
medication-taking behaviors (Takiya et al., 2004). Psychological constructs can be more
appropriate mechanisms for understanding what motivates differences in MA (Broadbent
et al., 2011; Schimittdiel et al., 2008).
Existing Research on Psychological Factors and Medication Adherence
Time perspective. Healthcare professionals can learn more about a patient’s
motivation toward health behaviors based on his or her time perspective (TP; Guthrie,
Butler, & Ward, 2009; Sansbury, Dasgupta, & Ward, 2012; Wills, Sandy, & Yaeger,
2001). The construct denotes a subconscious, cognitive process for making sense of
experiences from the past, prioritizing actions in the present, and setting goals for the
future (Zimbardo & Boyd, 1999). Literature indicates that adults with predominantly
future outlooks have better exercise habits (Guthrie, Lessl, Ochi, & Ward, 2013;
Löckenhoff & Carstensen, 2004), regular condom use, less substance abuse (Henson,
Carey, Carey, & Maisto, 2006), better psychological well-being, effective behavioral
coping, and higher sense of control (Wills et al., 2001). On the other hand, many
individuals with increased present perspectives, particularly those whose decisionmaking process is motivated by immediate gratification or a strict belief in predetermined
fate, report more substance abuse, risky sexual practices (Henson et al., 2006), gambling
issues (Hodgins & Engel, 2002), less sense of control, more negative affect, and more use
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of angry or maladaptive coping (Wills et al., 2001). Their viewpoints are called presenthedonistic or present-fatalistic time perspectives, respectively. In total, the implication
future time perspectives motivates people to invest energies toward anticipated long-term
consequences and likely health-promoting behaviors as well, whereas elevated present
time perspectives challenges one's willingness to prioritize behaviors according to similar
unobservable or delayed goals.
Few studies such as those completed by Sansbury et al. (2012) investigate the
relationship between time perspective and MA in chronic disease research. Sansbury et
al.’s outcomes substantiate that individuals with dominant future time perspectives
typically describe themselves as more adherent to prescribed antihypertensive drugs,
compared to others with less future time perspective (Table 1); however, the results do
not demonstrate statistically significant contrasts.

Table 1
Mean ± SE for Medication Adherence for All Time Perspective Traits

Variable
Antihypertensive medication
Completely nonadherent
Slightly adherent
Adherent on average
Mostly adherent
Completely adherent

Presenthedonistic

Presentfatalistic

Future

3.36 ± 0.33
2.40 ± 0.65
3.37 ± 0.15
3.12 ± 0.08
3.20 ± 0.06

3.00 ± 0.45
2.19 ± 0.61
2.95 ± 0.24
2.60 ± 0.13
2.60 ± 0.08

3.03 ± 0.27
2.97 ± 0.45
3.42 ± 0.20
3.80 ± 0.07
3.70 ± 0.05
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Given the lack of evidence for a direct effect, it is possible that identified age and
education effects contribute to an increase in reported drug use for people with more
future outlook. Forthcoming studies must provide better information about how time
perspective relates to clinically- and statistically-significant differences in adherence.
Health beliefs. A second psychological construct called health beliefs shows
clearer affiliations with medication adherence. For decades, clinical researchers and
proponents of the health belief model (Becker, 1974; Brown & Segal, 1996; Harvey &
Lawson, 2009) have interpreted patients’ motivation to complete prescribed treatment
based on their perceived likelihood of experiencing complications related to chronic
diseases (susceptibility) and interference with physical or mental functioning (severity).
A recent meta-analysis of 27 studies reveals that people who believe diabetes is more
threatening are more compliant with drug regimens; but those who do not describe the
chronic disease as severe are 22% less likely to be adherent (DiMatteo, Haskard, &
Williams, 2007). There are similar implications about perceived susceptibility and
medication-taking behaviors (Broadbent et al., 2011; Harvey & Lawson, 2009).
Primarily, individuals with elevated perception of disease susceptibility have higher MA,
fewer symptoms, and less illness-related stress (Broadbent et al., 2011). Mann et al.
(2009) infers that people who struggle with nonadherence often believe that diabetes has
few consequences and symptoms. In summary, it is clear that decreased perception of
disease severity and susceptibility can systematically inspire poor lifestyle choices and
thereby contribute to marginal illness management over time.
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Bridging the Gap with Health Locus of Control Beliefs
Considering existing discoveries on perception of disease severity and
susceptibility, a question remains if there are other types of health beliefs motivating
patients to take prescribed drugs. It is probable that a final construct called health locus of
control (HLC) would enable clinical researchers to add new knowledge to what we know
about MA. Wallston and Wallston (1981) broadly characterize HLC beliefs as the level
of control an individual believes he or she has over personal health. The founders’
manuscripts present a multidimensional construct encompassing three additional health
beliefs: internal locus of control, powerful others, and chance. These domains represent
the perception that treatment outcomes depend on personal actions, external authority
figures like medical professionals, or luck (Wallston & Wallston, 1981).
HLC beliefs may further explain differences in medication-taking behaviors
previously unattributed to time perspective or health beliefs. Existing chronic disease
studies already provide a basis for this assertion (Atkins & Fallowfield, 2006; Barclay et
al., 2007; Do, 2011). Among people with human immunodeficiency viruses (HIV), low
internal locus of control and high chance beliefs predict poor adherence to anti-retroviral
therapy (Barclay et al., 2007; Do, 2011). The two domains can explain 16 to 18% of
variance when specifically comparing younger adults’ adherence (Barclay et al., 2007);
on its own, a one point increase in chance beliefs can produce a 6% decrease in
adherence to anti-retroviral therapy (Do, 2011). According to a breast cancer study,
women with more powerful others beliefs are less likely to adhere to hormone regimens,
particularly if they think medical professionals or family members are more responsible
for managing conditions (Atkins & Fallowfield, 2006). Both internal and external loci of
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control appear integral to interpreting why patients take drugs. More research into
affiliations between HLC beliefs and MA is needed to determine the validity of these
inferences for people with hypertension or diabetes.
In summary, nonadherence is linked to avoidable healthcare costs and questions
regarding the benefits of medications among individuals with hypertension or diabetes.
Clinical researchers and healthcare professionals, more importantly, acknowledge that the
patients are more at risk for morbidity and mortality when they do not comply with
treatment. Psychological constructs seem to be vital to understanding individual
motivators that develop over a lifetime and influence prescription drug use.
Contemporary research suggests that future time perspective is better associated with
health-promoting behaviors than present time perspectives, yet there is no statisticallysignificant evidence corroborating similar contrasts in adherence. More conclusive
findings show that inconsistent health beliefs systemically inspire poor lifestyle choices
and indirectly contribute to marginal chronic disease management. Finally, there is
empirical support from prior investigations suggesting that health locus of control beliefs
can better explain variance in MA unattributed to the discussed psychological constructs.
To advance research on psychological constructs associated with health behaviors, it is
essential to determine how HLC beliefs add context to the magnitude and direction of
time perspectives’ and health beliefs’ relationships with adherence, particularly for
people with hypertension or diabetes.
Significance of the Study
In hopes of supporting an alliance with the medical community, the current study
illustrates how counselor educators provide unique insight into what motivates patient
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behavior. Counseling professionals receive training in clinical techniques and research
methodology to provide expertise pertaining to mental health in a variety of healthcare
settings. Their competency areas can include human development, assessment, family
and group dynamics, clinical supervision, consulting, and teaching (American Counseling
Association, 2013).
Counseling practitioners and educators can subsequently apply findings about
how psychological factors influence chronic disease management to train other healthcare
professionals in effective interventions. Several studies support the use of behavioral
interventions to treat medical illness (Duff & Latchford, 2010; Kahana, Drotar, & Frazier,
2008; Riekert, Borrelli, Bilderback, Rand, 2011; Rubak, Sandboek, Lauritzen, &
Christensen, 2005). According to Duff and Latchford (2011), behavioral techniques
focused on medication adherence can reduce symptoms for people with cystic fibrosis.
Motivational interviewing strategies increase adherence to diet and exercise
recommendations for those with cancer histories (Bennett, Lyons, Winters-Stone, Nail, &
Scherer, 2007; Pinto, Frierson, Rabin, Trunzo, & Marcus, 2005) and asthma (Schmaling,
Blume, & Afari, 2001). Counselor educators could train health professionals to
administer the psychological interventions in a single visit or as few as 15 minutes
(Rubak et al., 2005). They can also tailor the training to complement patients’ needs with
multifaceted approaches involving physician education about reflective listening,
supportive family or group sessions (DiMatteo et al., 2012), behavioral assessment,
reminders to refill prescriptions, and rewards that reinforce health behaviors (Haynes,
McDonald, & Garg 2002). Finally, it is important to note that teams working with a
person with a chronic disease may need some time to identify the optimal approach for

7

managing drug use on a long-term basis, so they must emphasize patient-centered care
and collaborative problem-solving to transition successes from the next appointment to
the years ahead (DiMatteo et al., 2012).
Purpose of the Study
The Clinical Trial and Outcomes Branch of the National Institute of Arthritis and
Musculoskeletal and Skin Diseases (NIAMS) granted access to archival data from its
health behavior protocol. The purpose of the current observational study is to test the
effects of time perspective, health beliefs, and health locus of control beliefs on
medication adherence for individuals with hypertension or diabetes.
Research Questions
The study used meditational path analysis of direct and indirect effects to answer
the following research questions.
Direct Effects
1a. What direct influence does age have on medication adherence among people
with hypertension or diabetes? Contemporary literature indicates that individuals’
medication use is significantly and positively associated with age (Barclay et al., 2007;
Hashmi et al., 2007). Older patients’ adherence rates can be twice as high as those for
their younger peers. Individuals between 70- and 80-years-old can have a 92% success
rate in taking antihypertensive medication (Hashmi et al., 2007).
Hypothesis 1a: I hypothesized that age would have a direct effect on medication
adherence; and I predicted a positive association with the outcome, meaning that older
people would report higher adherence than younger people.
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1b. What direct influence does time perspective have on adherence? Literature
signifies that adults with predominantly future outlooks have better exercise habits
(Guthrie et al., 2013; Löckenhoff & Carstensen, 2004), regular condom use, less
substance abuse (Henson et al., 2006), better psychological well-being, effective
behavioral coping, and higher sense of control (Wills et al., 2001). On the other hand,
many individuals with increased present perspectives, particularly those whose decisionmaking process are motivated by immediate gratification or a strict belief in
predetermined fate, report more substance abuse, risky sexual practices (Henson et al.,
2006), gambling issues (Hodgins & Engel, 2002), less sense of control, more negative
affect, and more use of angry or maladaptive coping (Wills et al., 2001). Their viewpoints
are called present-hedonistic or present-fatalistic time perspectives, respectively. Based
on comparing these findings, the implication is that future perspectives are better
affiliated with health-promoting behaviors than present traits, in contrast to associations
for unfavorable outcomes linked to present time perspectives.
Hypothesis 1b: I hypothesized that future time perspective would have a direct
effect and a positive association with medication adherence, meaning that individuals
with more future outlook would report higher adherence than those with more presenthedonistic perspectives. Additionally, I predicted that present-hedonistic time perspective
would not yield a direct effect on reported drug use.
Indirect Effects
2a. How is time perspective indirectly associated with adherence through
perception of disease severity? In a meta-analysis involving several patient groups,
DiMatteo et al. (2007) present that individuals who refer to their condition as more
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serious demonstrate higher MA, even if clinicians identify them as having poorer health.
Those who do not describe the illness as severe may be 22% less likely to be adherent. In
essence, the findings show that the subjective rating of the severity of chronic disease is
just as valuable as a clinician's rating of health status in predicting medication-taking
behavior.
Hypothesis 2a: I hypothesized that perception of disease severity would mediate
the effect of time perspective on medication adherence differently. I believed that
participants’ future and present-hedonistic outlooks could operate through this health
belief to influence medication adherence indirectly.
2b. How is time perspective indirectly associated with adherence through
perception of susceptibility to future complications? Individuals with elevated perception
of disease susceptibility have higher MA, fewer symptoms, and less illness-related stress
(Broadbent et al., 2011). Mann et al. (2009) infers that people who struggle with
nonadherence often believe that diabetes has few consequences and symptoms.
Hypothesis 2b: I hypothesized that perception of susceptibility to future
complications would mediate the effect of time perspective on medication adherence
differently. I believed that participants’ future and present-hedonistic outlooks could
operate through this health belief to influence medication adherence indirectly.
3. How is time perspective indirectly associated with adherence through internal
locus of control? Several diabetes investigations unanimously indicate that HbA1c
metabolic control improves among people with more internal locus of control
(Macrodimitris & Edner, 2001; O’Hea et al., 2005; Surgenor, Horn, Hudson, Lunt, &
Tennent, 2000). Based on Morowatisharifabad and colleagues (2009), this single HLC
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belief is the best predictor of successful adherence, even when individuals believe that
fate or chance also influence health status at times.
Hypothesis 3: I hypothesized that internal locus of control would mediate the
effect of time perspective on medication adherence; and I predicted a positive association
between this HLC belief and MA, meaning that time perspective would operate through
elevated internal locus of control to increase drug use.
4. How is time perspective indirectly associated with adherence through external
locus of control? Studies into how health locus of control beliefs influence medication
adherence offer that both externality and internality can motivate a person to complete
treatment (Atkins & Fallowfield, 2006; Barclay et al., 2007).
Hypothesis 4: I hypothesized that external locus of control would mediate the
effect of time perspective on medication adherence differently.
Procedure
The Clinical Trials and Outcomes Branch implemented health behavior protocols
from July 2006 to August 2010 in three cities near Washington, D. C. - Silver Spring,
Maryland; Hagerstown, Maryland; and Martinsburg, West Virginia. To recruit
multicultural community samples, the staff surveyed patrons of beauty shops and
barbershops in working-class and more affluent neighborhoods. They then met with
community members to explain the study, determine eligibility, and obtain verbal
informed consent. The staff had the following inclusion criteria: being 18-years-old or
older, being literate in English, and being able to provide informed consent.
The current study pertained to data collected in Martinsburg, because the city
cohort contained the most robust information on psychological constructs and health
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behaviors. In this city cohort, 98 participants reported ever being diagnosed with high
blood pressure or diabetes by a physician. The final group of 79 individuals consisted of
those who took prescribed antihypertensive or antidiabetic drugs during the study.
Statistical Analyses
I considered eight variables in the total model: medication adherence as a criterion
variable; present-hedonistic and future time perspectives as predictor variables; perceived
disease severity, perceived susceptibility to future complications, external locus of
control, and internal locus of control as mediators; and age as a covarying predictor
variable.
I chose to do path analysis for several reasons. First, it enabled me to examine
structural relationships between nonnumeric categories of psychological factors and
beliefs (Yu, 2002); moreover, it simultaneously examined direct effects and indirect
effects of continuous predictor variables and categorical mediators on categorical
outcomes. I also selected path analysis because it enabled me to determine the relevance
of psychological constructs on medication adherence by calculating total model fit, which
compared the hypothesized total model with a restricted baseline model (Muthén, 19982004; Yu, 2002). To accomplish these goals, I ran several tests, including the chi-square
statistic and root mean square error of approximation (RMSEA), with estimates below
0.08 and probability above 0.05 as criterion for assessing goodness-of-fit (Muthén &
Muthén, 1998-2010). The equation for RMSEA was

v((χ2/(n*d)) - (1/n))*v(g),
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where d represented degrees of freedom; n represented total sample size; χ2 represented
the chi-square statistic; and g represented the number of groups (Muthén, 1998-2004).
I also considered two incremental fit indices- comparative fit index (CFI) and
Tucker-Lewis Index (TLI) - with 0.95 to 0.99 repeating as additional criteria.
Contemporary writers have recognized these conventional cut-offs for preventing Type II
error with sample sizes smaller than 100 (Hu & Betler, 1999; Muthén, 1998-2004; Yu,
2002). The equations were

TLI = (χ2B/dfB - χ2H0/dfH0) / ( χ2B/dfB – 1) and
CFI = 1 – max (χ2H0 - dfH0,0)/ max (χ2H0 - dfH0, χ2B - dfB, 0),

where χ2B represented the chi-square statistic for the baseline model; dfB represented
degrees of freedom for the baseline model; χ2H0 represented the chi-square statistic for the
hypothesized model; and dfH0 represented the degrees of freedom for total model
(Muthén, 1998-2004).
Definitions
Counselor educator. The advanced counseling professionals receive doctorallevel training in clinical techniques and research methodology to provide expertise
pertaining to mental health in a variety of healthcare settings. The competency areas can
include human development, assessment, family and group dynamics, clinical
supervision, consulting, and teaching.
Diabetes. The condition, clinically referred to as diabetes mellitus, encompasses a
set of diseases characterized by elevated sugar levels in blood.
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Health beliefs. Health beliefs are a set of values and expectations that motivate
health-related behaviors. For instance, perceived severity depicts feelings about the
seriousness of developing a chronic disease. This perception also includes evaluations of
any consequences to changing health status, like injury or decreasing work
responsibilities. Likewise, perceived susceptibility illustrates how vulnerable a person
believes he or she is to secondary complications related to chronic diseases. Perception of
disease severity and perception of susceptibility to future complications are two predictor
variables.
Health locus of control beliefs. Health locus of control beliefs denote people's
expectations that their health status is controlled by personal behavior or external
influence. The multidimensional construct encompasses three health beliefs: internal
locus of control, powerful others, and chance. These domains represent the perception
that outcomes depend on personal actions, external authority figures like medical
professionals, or luck. The current study divides the health locus of control construct into
two mediator variables- internal locus of control and external locus of control.
Hypertension. Hypertension, also called high blood pressure, denotes an inability
to maintain systolic blood pressure below 140 mmHg and diastolic blood pressure below
90 mmHg.
Medication adherence. Medication adherence is the extent to which patients’
behaviors correspond with instructions by healthcare providers to take prescribed drugs
in hopes of treating conditions. Medication adherence is the criterion variable.
Time perspective. Time perspective represents a person's subconscious way of
making sense of experiences from the past, prioritizing actions in the present, and setting
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goals for the future. To illustrate, individuals with more future time perspectives
prioritize behaviors and invest their energies toward anticipated long-term consequences.
People with dominant present time perspectives decipher needs and resources to make
decisions based on immediate cues from their environments. In particular, their decisionmaking process can be motivated by being spontaneous and seeking pleasure (hedonistic
domain) or a strict belief in predetermined fate (fatalistic domain). The time perspective
construct is divided into three predictor variables: future, present-hedonistic, and presentfatalistic outlooks.
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CHAPTER 2
Literature Review
Medication adherence (MA) is the extent to which people's behaviors correspond
with instructions by healthcare providers to take prescribed drugs in hopes of treating
conditions (Atkins & Fallowfield, 2006; Morowatisharifabad, Mazloomy,
Baghianimoghadam, & Rouhani Tonekaboni, 2009). It encompasses a range of health
behaviors, like taking necessary pill dosages at the appropriate time of day, as opposed to
an outcome. To further explain, an individual's adherence to antihypertensive drugs
contributes to blood pressure control; but one can still maintain elevated diastolic and
systolic pressure levels when consistently taking medications (DiMatteo, HaskardZolnierek, & Martin, 2012), especially if he or she does not follow other components of a
treatment regimen. Inherently, the construct also represents how nonadherent patients are
to drugs (Alhalaiqa et al., 2012). Nonadherence occurs when a person intentionally
neglects, unintentionally forgets, or simply fails to complete instructions for medications
(i.e. eating food with them). The following literature review references adherence and
nonadherence, instead of compliance and noncompliance, because the former terms
emphasize a patient's decision-making and collaboration with health professionals
(DiMatteo et al., 2012).
The Importance of Medication Adherence
Although the consequences of drug use vary by illness, people who say they have
better MA are nearly three times more likely to experience health benefits than
individuals with poor adherence. Peers who report nonadherence often stand the best
chances of improving health status with more consistent medication use (DiMatteo, 2004;
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DiMatteo et al., 2012), particularly if they have conditions that respond well to
pharmaceutical therapies. Overall, intricacies related to taking medications for high blood
pressure and diabetes represent the difficulties associated other chronic diseases well and
thus make befitting representations.
The Disease Burden of Hypertension
Nearly 70 million or 22% of U.S. residents have hypertension (Centers for
Disease Control, 2012). Broader estimates indicate that one billion people around the
world have the chronic disease (Kearney et al., 2005). Hypertension, also called high
blood pressure, denotes their inability to maintain systolic blood pressure below 140
mmHg and diastolic blood pressure below 90 mmHg. It has been identified as the third
leading cause of early death or years lost to illness around the world (Kearney et al.,
2005). While still alive, an individual is at risk for serious injury due to increased
likelihood of having cardiovascular disease or a stroke (Alhalaiqa et al., 2012; Hashmi et
al., 2007).
The Disease Burden of Diabetes
Close to 26 million or 8.3% of U.S. residents have diabetes (Centers for Disease
Control, 2011). The diagnosis, clinically referred to as diabetes mellitus, pertains to a set
of diseases characterized by elevated sugar levels in blood. There are three diagnostic
criteria- having A1c hemoglobin levels above 6.5%, having blood sugar levels above 126
milligrams per deciliter before food, or having sugar levels above 200 milligrams per
deciliter two hours after eating (Centers for Disease Control, 2011). The potential disease
burden for people who meet one of these criteria may increase over time. At least 90% of
all new cases occur because individuals’ pancreases stop producing insulin after limited
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physical activity and poor metabolism (Centers for Disease Control, 2011). Those who
acquire diabetes are more acutely at risk for a host of potentially fatal secondary
ailments- including kidney failure, blood vessel clotting, amputation of the legs or feet,
blindness, cardiovascular disease, and stroke.
Understanding Medication Adherence for Both Diseases
In total, there are roughly 100 million or 30% of U.S. residents with hypertension,
diabetes, or both chronic diseases. One Kaiser Permanent study reveals that 81% or
nearly 131,000 of 161,697 of Northern California patients with diabetes also have high
blood pressure (Schimittdiel et al., 2008). It is clear that these people and others like them
have chronic diseases with unique diagnostic criteria; however, medication adherence
researchers have recently investigated hypertension and diabetes simultaneously for a few
reasons (Broadbent et al., 2011; Mann et al., 2009; Schimittdiel et al., 2008). First, the
individuals with single or co-occurring diseases initially experience few symptoms, yet
they must take drugs with delayed tangible health benefits. The advantages of adhering
on a daily basis accrue over time, in other words. Additionally, contemporary literature
indicates that managing the chronic diseases requires similar medication-taking
behaviors, given that physicians prescribe an oral medication for the majority of people
with hypertension or diabetes (Lau & Nau, 2004; Pladevall et al., 2004). Many
individuals with diabetes even take antihypertensive medications to prevent fat depositing
in arteries in a condition called atherosclerosis (Mann et al., 2009; Schimittdiel et al.,
2008). Lastly, patients typically administer drugs themselves for diabetes and
hypertension, barring for the most severe medical crises when hospital staff intravenously
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deliver them, so researchers can generally attribute adherence or nonadherence to an
individual’s own decision-making process (Löckenhoff & Carstensen, 2004).
Adherence decreases disease burden by minimizing symptoms and mitigating
risks associated with preventable secondary complications (Alhalaiqa et al., 2012; Conn
et al., 2009; Hashmi et al., 2007). A person that decreases his or her systolic blood
pressure to below 115 mmHg with antihypertensive medication takes the single most
important step to decrease chances of having cardiovascular disease or stoke (Alhalaiqa
et al., 2012). Reducing hypertension risk also improves cholesterol and hemoglobin
levels for patients taking insulin for diabetes (Schimittdiel et al., 2008). In essence, there
are additive benefits to successful adherence.
Equally and in a contrasting way, the disadvantages of poor MA add up for
individuals with chronic diseases. Kripalani et al. (2007) offers that 66% of individuals
with hypertension do not take prescribed antihypertensive medications as directed, which
is akin to the 64% of people with diabetes who struggle with nonadherence (Cramer,
2003; DiMatteo, 2004; Walker et al., 2006). Individuals with lower MA are three times
less likely to experience intended health benefits than peers with better adherence (Conn
et al., 2009). Prolonged nonadherence can also worsen the disease severity so much so
that previously minor diagnoses grow into fatal cases (Conn et al., 2009).
It is imperative, therefore, to ask why patients are not taking the medications that
effectively manage high blood pressure or diabetes. Preliminary investigations into this
question show that individuals adhere less because they want to avoid immediate side
effects (Osterberg & Blaschke, 2005; Sluijs et al., 2006). There is also evidence that
patients dismiss the long-term benefits of better nutrition or lifestyle choices due to the
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initially asymptomatic or silent nature of chronic diseases (Takiya et al., 2004). Even
without absolute confirmation, is clear that nonadherence is more common than
adherence.
Existing Knowledge on Medication Adherence
Existing studies point out several predictors and risk factors related to medicationtaking behaviors (Barclay et al., 2007; Conn et al., 2009; Hashmi et al., 2007; Kothawala,
Badamgarav, Ryu, Miller, & Halbert, 2007; Mann et al., 2009; Nieuwherk & Oort, 2005;
Schimittdiel et al., 2008; Takiya et al., 2004). To begin with the findings on predictors,
MA is significantly and positively associated with age (Barclay et al., 2007; Hashmi et
al., 2007). Older patients’ adherence rates can be twice as high as those for younger
peers. Individuals between 70- and 80-years-old can have a 92% success rate in taking
antihypertensive medication (Hashmi et al., 2007). The amount of time since diagnosis
can be a second predictor of lower MA (Kothawala et al., 2007; Takiya et al., 2004). In
other words, any failure to take medications only increases without intervention. This
assertion is consistent with an earlier finding that the percentage of individuals reporting
nonadherence rises from 6 to 66% in the first three years after diagnosis (Levy, 1989).
The list of risk factors exemplifies how realities beyond a person’s control can
make him or her more susceptible to nonadherence. To illustrate, patients with chronic
diseases can spend as much as $8,305.89 over five years for medication (Balkrishnan et
al., 2003). Individuals receiving private insurance reimbursements or Medicare services
typically report higher MA, whereas people with limited or no coverage say that out-ofpocket costs often prevent them from accessing prescribed drugs (Balkrishnan et al.,
2003; Mojtabai & Olfson, 2003). For those who can receive treatment, taking more than
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one medication significantly raises risk for nonadherence (Conn et al., 2009; Iskedjian et
al., 2002), just as an individual is more likely to struggle with MA if he or she has to take
any prescribed pills more than once a day (Takiya et al., 2004). Clinicians refer to these
phenomena as dosing frequency effects.
Issues in Medication Adherence Research
Despite what researchers already know about risk factors and predictors for
nonadherence, discrepancies in the existing research uncover several questions about how
investigators collect data and interpret patient motivation. In particular, a large majority
of information comes from White people in single-site pilot programs or research hospital
studies (DiMatteo et al., 2007). Such convenient recruitment captures the opinions of
patients who can be more inherently motivated and have better resources to improve their
health status (Patel & Taylor, 2002). Consequently, community settings can provide
better means to gather data from participants whose motivations are more representative
of the general patient population.
Mann et al. (2009) offers the only study based in a community setting. The
participant group largely consists of Black or Hispanic individuals who are low-income
earners, unemployed, and have less than high school educations. Barring this exception,
the next limitation is an inability to generalize medication adherence research to
multiculturally diverse patient groups, thereby limiting credibility in applying new
knowledge to underserved populations with chronic diseases. There are fewer studies
evaluating individual motivators among patients who allegedly are at-risk for
nonadherence and adverse health. There is potential that including more minorities and
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working-class participants could expose intersecting indirect effects from psychological
constructs, even if minority status does not directly influence treatment adherence.
Another limitation is a discrepancy in data collection tools. There are a number of
methods for gathering information- including patient questionnaires and interviews,
healthcare provider reports, manual pill counting, electronic pill bottles, and biological
assays for drug levels (Atkins & Fallowfield, 2006; Ye, Krupka, & Davidson, 2012); and
clinical researchers have issues identifying a single standardized approach for measuring
MA. Each method presents challenges like underreporting, time constraints, or high
costs. Still, a growing consensus is that there is little difference when comparing
medication use between self-reports and more objective measures (Atkins & Fallowfield,
2006; Poweles, Eeles, & Ashley, et al., 1998).
The final limitation, and perhaps the most relevant one, is in converting
discoveries on predictors and risk factors into knowledge about individual motivation.
Discussed demographic and biomedical variables like age, number of prescribed pills,
and dosing frequency are external factors that individuals can neither determine nor
modify (Harvey & Lawson, 2009). Therefore, it is more logical to discuss them in terms
of epidemiological trends in public health outcomes. It is not valid to refer to these
factors as intrinsic motivators.
Psychological Constructs Motivate Medication Adherence
Clinical researchers are already looking at internal phenomena specifically to
interpret why patients are more or less adherent to medication regimens (Broadbent et al.,
2011; DiMatteo et al., 2007; Mann et al., 2009). Studies employ various psychological
models to decipher how health behaviors develop over a lifetime. For instance, the theory
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of reasoned action asserts that individuals behave according to information they have
about specific health outcomes (Ajzen & Fishbein, 1980; Fishbein & Ajzen, 1975). This
model also suggests that people's cognitive schema or expectations about a diagnosis
develop in social environments, particularly interactions with family members or medical
professionals. Secondly, the theory of planned behavior offers that individuals respond to
treatment according to available resources for overcoming perceived barriers (Ajzen,
1985). It especially highlights the importance of locus of control and self-efficacy as
motivators. Finally, the health belief model hypothesizes that a set of values and
expectations of benefit motivate health-related behaviors (Becker, 1974; Rosenstock,
1974). Compared to the others, clinical researchers use this last conceptual model to
interpret use of prescribed drugs (Broadbent et al., 2011; DiMatteo et al., 2007; Mann et
al., 2009). The following literature review elaborates on the relationships between
psychological constructs and MA. To do so, it will explore findings related to time
perspective (TP), health beliefs, and health locus of control (HLC) beliefs.
Time Perspective
Defining Time Perspective
Time perspective (TP) represents a person's subconscious way of making sense of
experiences from the past, prioritizing actions in the present, and setting goals for the
future (Zimbardo & Boyd, 1999). It is a foundational cognitive structure that develops
from repetitive or nonreoccurring life experiences, and it consequently motivates how an
individual makes new decisions (Zimbardo & Boyd, 1999). There is a link between time
perspective and behavior. In theory, a person who relies on what he or she learned in the
past will behave based on insight gained from prior analogous situations in life. The

23

recall of potential benefits or costs may be nostalgic, traumatic, accurate, or reconstructed
memories (Zimbardo & Boyd, 1999). Contrastingly, individuals with more future
orientation act according to desired long-term rewards. Their anticipation serves as an
intrinsic force driving assessments of how current actions will facilitate goals or alternate
outcomes.
The Evolution of Time Perspective Research
The concept of TP has evolved since the late 1990s. Initial assumptions broadly
characterized people as having either present or future orientations (Zimbardo & Boyd,
1999). The theorists believed that they consistently favored one outlook over another, so
much so that decision-making and actions remained consistent from one situation to the
next. Conversely, more recent scholars say that an individual can have more situational or
blended perspectives that evolve over time, particularly when new situations or life
periods require change (Guthrie et al., 2009; Löckenhoff & Carstensen, 2004). The newer
descriptions refer to TP with multidimensional domains called past-positive, pastnegative, present-fatalistic, present-hedonistic, and future (Hamilton, Kives, Micevski, &
Grace, 2003). The last three perspectives have been especially instrumental in
understanding health behaviors in recent years.
Time Perspective and Health Behaviors
Time perspective research makes it increasingly clear that the psychological
construct can be a broader mechanism that inspires health behaviors. As an example,
literature signifies that adults with predominantly future outlooks have better exercise
habits (Guthrie et al., 2013; Löckenhoff & Carstensen, 2004), consistent condom use, less
substance abuse (Henson et al., 2006), better psychological well-being, effective
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behavioral coping, and higher sense of control (Wills et al., 2001). On the other hand,
many individuals with increased present perspectives, particularly those whose decisionmaking process are motivated by immediate gratification or a strict belief in
predetermined fate, report more substance abuse, risky sexual practices (Henson et al.,
2006), gambling issues (Hodgins & Engel, 2002), less sense of control, more negative
affect, and more use of angry or maladaptive coping (Wills et al., 2001). Their viewpoints
are called present-hedonistic or present-fatalistic time perspectives, in order. Based on
comparing these findings, the implication is that future outlook is better affiliated with
health-promoting behaviors than present outlook, in contrast to associations with
unfavorable outcomes linked to present time perspectives.
Only one health behavior study has tested the effect of TP on medication-taking
behaviors for participants with hypertension (Sansbury et al., 2012). The results illustrate
that individuals with predominantly future orientation follow antihypertensive drug
regimens better than peers with present outlooks (Table 1), despite lacking statistically
significant correlations between TP and adherence. It is likely that the increase in MA for
participants with future perspectives depends on identified age and education effects.
Scholars have not published replication studies to explore how TP directly affects
individual differences in adherence.
Limitations and Related Research Questions
The relevant limitation in time perspective studies is that there has only been one
investigation considering how the psychological construct motivates adherence.
Nonetheless, the existing knowledge about TP and other health behaviors points to new
questions for consideration. A major finding is that people with more present orientations
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navigate health decisions based on concrete, observable realities (Guthrie et al., 2009;
Löckenhoff & Carstensen, 2004). Therefore, forthcoming studies must evaluate if those
with present-hedonistic outlooks have lower MA because they prioritize immediate
gratification and avoiding discomfort. Any nonadherence may be attempts to minimize
undesired, but expected, lifestyle changes or side effects. In addition, it is possible that
individuals with elevated present-fatalistic orientations, denoted by strict belief in
predetermined fate, have little faith in efforts to improve symptoms with better health
behaviors. Published studies on time perspective indicate that the present perspectives are
inversely correlated with future ones (Guthrie et al., 2009; Guthrie et al., 2013). If people
with predominantly future orientations prioritize behaviors and invest their energies
based on anticipated long-term consequences, it is more likely that their decision-making
process promotes medication-taking behaviors. Investigators need to evaluate
associations between TP and MA to verify the validity of these inferences.
Health Beliefs
Defining Health Beliefs
Health beliefs are a set of subjective values and expectations that motivate healthrelated behaviors like complying with treatment demands (Becker, 1974; Rosenstock,
1974). The psychological construct includes six distinct dimensions: (1) perceived
severity or interference with physical and mental functioning, (2) perceived potential
threat from a medical condition, (3) perceived barriers, (4) perceived benefits, (5)
behavioral cues, and (6) modifying factors (Brown & Segal, 1996). Theorists and clinical
researchers reference the first four perceptions the most (Brown & Segal, 1996; Janz &
Becker, 1984), so they will only be discussed for the sake of brevity. The perceived
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severity dimension depicts feelings about the seriousness of developing a chronic
condition. This perception also involves evaluations of any consequences for changes in
health status, such as injury or decreasing work responsibilities. Next, the perceived
susceptibility domain depicts how vulnerable a person believes he or she is to secondary
complications or new illnesses. Perceived benefits describe the degree to which an
individual believes specific treatments will be successful for curing or managing a
condition. Finally, the perceived barriers domain represents the awareness of any
challenges that impede individuals from taking necessary actions to improve their health
(Brown & Segal, 1996).
The Evolution of the Health Belief Model
In the mid-20th century, a group of social psychologists introduced the idea of
health beliefs to explain why patients did not participate in preventative care or screening
tests at the U.S. Public Health Service (Becker, 1974; Janz & Becker, 1984; Rosenstock,
1974). The multidimensional model gained popularity from 1966 to 1987 when clinical
researchers published as many as 16 studies relating patient behavior to health beliefs
(Harrison, 1992). Since the turn of the 21st century, proponents of the model (Broadbent
et al., 2011; Harvey & Lawson, 2009; Mann et al., 2009) concentrate on medicationtaking behaviors in particular; they have published over 100 publications on MA
(DiMatteeo et al., 2007).
Today, there is a broad understanding that “the decision to comply with medical
regimens ultimately lies with the patient within the context of [her or his] beliefs and
values” (Brown & Segal, 1996, p. 903). Individuals that have chronic diseases, like
hypertension and diabetes, can make a series of trade-offs after receiving new medical
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information (Harvey & Lawson, 2009; Löckenhoff & Carstensen, 2004). These tradeoffs, especially weighing short-term discomforts against health over time, can determine
how well they manage symptoms and even complications brought on by treatment
(Löckenhoff & Carstensen, 2004). It is understood that people take inventory of external
resources like finances to do so (Barclay et al., 2007); furthermore, the following
contemporary health belief findings largely support the premise that internal phenomena
can also influence decision-making.
General Findings on Health Beliefs and Medication Adherence
Several contemporary studies have applied the health belief model to understand
medication adherence among individuals with chronic diseases (Barclay et al., 2007;
Barnes et al., 2004; DiMatteo et al., 2007; Mann et al., 2009). In a meta-analysis
involving several patient groups, DiMatteo et al. (2007) say that individuals who refer to
their condition as more serious demonstrate higher MA, even if clinicians identify them
as having poorer health. Those who do not describe the illness as severe may be 22% less
likely to be adherent. In essence, the findings show that the subjective rating of the
severity of chronic disease is just as valuable as a clinician's rating of health status in
predicting medication-taking behavior.
In addition to the meta-analysis, there are a host of publications employing the
health belief model as a framework for interpreting MA to diabetes drugs (Aikens &
Piette, 2009; Barnes, Moss-Morris, & Kaufusi, 2004; Harvey & Lawson, 2009; Mann et
al., 2009; Weiland, Nguyen, & Jelinek, 2012). Fewer studies concentrate on hypertension
alone (Hashmi et al., 2007; Sansbury et al., 2012); and the smallest number of
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investigations focus on co-occurring hypertension and diabetes cases (Mann et al., 2009;
Schimittdiel et al., 2008).
Discoveries from diabetes-only studies emphasize the significance of health
beliefs when comparing participants’ medication-taking behaviors. Mann et al. (2009)
proposes that people who are less adherent may believe their illnesses come and go with
symptoms. The results reveal that those who only take prescribed drugs when blood sugar
is high, undoubtedly lowering the effectiveness of the treatment regimen to prevent crises
over time, are over 35% more likely to report nonadherence. Based on a similar study of
African-American adults with limited health literacy, Aikens and Piette (2009) suggest
that unrealistic concerns about medication discourage MA. The researchers elaborate that
many nonadherent people have unsubstantiated fears about experiencing adverse side
effects or addiction to drugs. There are similar implications about perceived susceptibility
and prescription drugs (Broadbent et al., 2011; Harvey & Lawson, 2009). Most notably,
individuals with elevated perception of disease susceptibility have higher MA, fewer
symptoms, and less illness-related stress (Broadbent et al., 2011). Mann et al. (2009)
infers that people who struggle with nonadherence generally believe that diabetes has few
consequences and symptoms.
The two hypertension studies have mixed results on health beliefs (Hashmi et al.,
2007; Sansbury et al., 2012). Like some people with diabetes, evidence supports that
nonadherent groups believe the high blood pressure comes and goes with symptoms
(Hashmi et al., 2007). The implication is that patients who think each antihypertensive
pill contributes to overall health have better adherence, and they experience lower
diastolic and systolic blood pressures. The investigation by Sansbury and colleagues
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(2012) does not go as far in recognizing individual differences in MA according to health
beliefs; the findings verify that nonadherence is associated with conflicting health beliefs,
particularly if individuals with hypertension understand the current seriousness of the
illness but fail to interpret susceptibility to future consequences. Nonetheless, the analysis
fails to identify any statistically-significant effects from perception of hypertension
severity or perception of susceptibility on reported drug use (Figure 1).
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Figure 1. Mediator path diagram of total model for medication adherence. * p <.05. **p
<.001.

The investigations for individuals with the two chronic diseases may provide the
most descriptive illustrations of what deters medication-taking behaviors. In particular,
Mann et al. (2009) cites one research participant who says, "you only have diabetes when
your blood sugar is high, [and] the consequences of diabetes are minimal" (p. 280). The
results corroborate that people with lower MA frequently have concerns that medical
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treatment will interfere with their social lives or lead to addiction to prescribed pills.
According to a related investigation, Schittdiel et al. (2008) suggests that improving
health beliefs and intensifying treatment with a psychoeducation seminar on medications
can significantly lower an individual's risk for cardiovascular events. The outcomes also
imply that those who do not receive these solution-focused interventions will maintain
nonadherence over time. In all, there is substantial support from observational and
intervention studies that improving health beliefs can enhance medication-taking
behaviors.
Health Locus of Control Beliefs
Defining Health Locus of Control Beliefs
A final psychological construct, health locus of control (HLC), denotes people's
expectations that personal behavior or outside forces influence control health status.
Proponents broadly separate HLC beliefs into two components- internal locus of control
and external locus of control (Wallston & Wallston, 1981; Wallston et al., 1978).
According to theory, a person with elevated internal locus of control attributes changes in
a medical condition to his or her own actions. The people with more external loci defer to
the authority of others for influencing health outcomes.
The Evolution of the Multidimensional Health Locus of Control Model
The idea of HLC beliefs dates back to a larger discussion about locus of control
from the mid-20th century. Rotter (1966) anchors the older concept in social learning
theory, defining HLC beliefs by stating:
When a reinforcement is perceived by the subject as following some action of his
own but not being entirely contingent upon his action, then, in our culture, it is
typically perceived as the result of luck, chance, fate, as under the control of
powerful others, or as unpredictable because of the great complexity of the forces
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surrounding him. When the event is interpreted in this way by an individual, we
have labeled this a belief in external control. If the person perceives that the event
is contingent upon his own behavior or his own relatively permanent
characteristics, we have termed this a belief in internal control. (p. 1)
According to Rotter’s description, people behave or respond based on an anticipated
outcome. The self-reinforcing relationship between past experiences and existing
expectations serves as an intrinsic stimulus to motivate them to perform new actions.
The biomedical community readily embraced the locus of control construct and
published more than 600 publications in the first 10 years after its early descriptions
(Rotter, 1975). Today, clinical researchers know that locus of control affects satisfaction
among patients with tuberculosis (Seeman & Evans, 1962), health literacy related to
diabetes (DuCette, 1974; Lowery & Ducette, 1976), and success with weight loss plans
(Salzer, 1978). Contemporary researchers apply terms like health-externals and healthinternals to describe patients receiving diabetes care (Wallston, Wallston, Kaplan, &
Maides, 1976; Wallston & Wallston, 1981). The people called health-externals score
above average on HLC surveys, indicating the belief that they have little control over
symptoms; instead, they surmise that chance, luck, fate, and powerful others are more
influential in determining if they are sick or healthy. On the other hand, health-internals
receive HLC scores that are below the mean and report that personal behavior determines
symptoms and chronic disease status.
Today, many clinical researchers follow the Rotter model in separating HLC
beliefs into internality and externality (Kuwahara et al., 2004; Ruffin, Ironson, Fletcher,
Balbin, Schneiderman, 2011; Wang et al., 2002). Others further divide the psychological
construct into internal locus of control, chance externality, and powerful others
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externality domains (Egan et al., 2009; Evans, Ferrando, Rabkin, & Fishman, 2000;
Morowatisharifabad et al., 2009). Both models contribute relevant knowledge about
general health behaviors and MA.
Existing Knowledge on Health Locus of Control
Social determinants. Observational studies highlight several social determinants
as predictors of HLC beliefs. For instance, investigators associate higher internal locus of
control with being younger (Egan et al., 2009) and having more formal education
(Morowatisharifabad et al., 2009); whereas, they connect increased external locus of
control, or a higher combination of chance and powerful others externality, to women and
people with less education (Kuwahara et al., 2004). People with more chance beliefs
typically have less education (Egan et al., 2009; Morowatisharifabad et al., 2009). Older
adults generally endorse elevated powerful others externality (Egan et al., 2009).
The findings on external locus of control and age are not as conclusive. In an
investigation with Iranian patients (Morowatisharifabad et al., 2009), there is support that
younger people tend to defer to the authority of others for accomplishing health goals. A
second study points to a similar age contrast in externality among generally healthy
individuals in Japan (Kuwahara et al., 2004). However, a study of Hispanic American
women receiving obstetric and gynecological care does not corroborate that younger
patients defer to others to improve health status (Roncancio, Ward, & Berenson, 2011),
likely because the group included fewer middle-aged or older adults.
General health behaviors. Studies comparing the role of HLC beliefs on general
health behaviors offer varied results. In regard to adverse outcomes, clinical researchers
write that externality is positively associated with higher body fat levels (Egan et al.,
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2009), cigarette smoking, excessive alcohol consumption (Kuwahara et al., 2004),
depression, life stress (Evans et al., 2000), and helplessness (Rabkin, Williams,
Neugebauer, Remien, & Goetz, 1990). They also correlate increased internality with
health benefits- namely less helplessness (Rabkin et al., 1990) and increased likelihood of
surviving a lung transplant (Burker, Evon, Galanko, & Egan, 2005). It appears that the
comparative advantages of internal locus of control supersede those of external locus of
control by these findings.
However, there is also compelling information that externality contributes to
positive outcomes. Results show that people with greater chance beliefs can experience
less depression, anxiety, and hostility about HIV status (Jenkins & Patterson, 1998); an
individual who ascribes to an external locus of control may have fewer depression
symptoms (Wang et al., 2002); and a person with more confidence in healthcare
providers can improve his or her likelihood of living longer with AIDS. These
discoveries on the benefits of externality, alongside internality, support assertions by a
few theorists. How does external locus influence health-promoting behaviors? Based on
one theory (Seeman & Evans, 1962), patients profit from relying on doctors when they
acquire meaningful feedback and information on the advantages of adhering to treatment,
and others benefit when they depend on trustworthy family members and peers for care.
Overall, having social support enables them to share responsibility in working toward
better nutrition or lifestyle changes (Schlenk, 1984).
Medication adherence. Investigations into how HLC beliefs impact adherence
also point to the advantages of both externality and internality. To start, there is some
evidence that the benefits function differently based on gender. Higher MA is associated
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with internal locus of control for males with kidney failure, where it is associated with
lower internal of control for females (Takaki & Yano, 2006). A second observation, and
likely the more important one, is that externality and internality domains can operate
independently to improve adherence. For example, literature indicates that decreased
powerful others and internal locus of control beliefs among women inspire better
adherence to hormone regimens for breast cancer care (Atkins & Fallowfield, 2006).
There is also evidence that elevated chance beliefs and decreased internal locus of control
beliefs function simultaneously to encourage compliance to antiretroviral therapy for
younger adult males with HIV (Barclay et al., 2007).
In regard to the specific chronic diseases considered by the proposed study,
contemporary research focuses more on patients with diabetes than hypertension to
compare HLC beliefs and MA. Diabetes investigations largely analyze sugar levels in
hemoglobin as a biological measure of adherence (Macrodimitris & Edner, 2001; O’Hea
et al., 2005; Surgenor et al., 2000). The findings unanimously indicate that HbA1c
metabolic control improves among people with more internal locus of control. According
to Morowatisharifabad et al. (2009), this single HLC belief is the best predictor of
successful adherence, even when individuals believe that fate or chance also influence
health status. Internal locus of control and chance beliefs together can explain over 9% of
variance in biological measures of MA (Morowatisharifabad et al., 2009). It is unclear
whether or not this support for internality would be replicated with self-reported drug use.
There is little research exploring if and how externality contributes to selfreported MA, yet the available information appears generally indicative of a potential
advantage for people with hypertension. Results demonstrate that a person who attributes
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his or her health status to nonmodifiable factors like a higher power or bad luck can
comply better with antihypertensive drug regimens (Patel & Taylor, 2002); and some
people with predominant externality beliefs show better adherence and less co-occuring
depression over a year (Wang et al., 2002). It is possible that others neglect to take
antihypertensives due to favoring alternative treatments against a doctor’s orders (i.e.
simply losing weight, stopping smoking, or minimizing salt intake). In total, another
implication is that external locus of control serves as a protective factor against
psychological distress by allowing patients to look outside themselves for optimism about
chronic diseases (Wang et al., 2002). Therefore, any resulting reduction in helplessness or
hopelessness could indirectly boost morale and encourage health-promoting behaviors
like MA.
Limitations and Future Directions
The limitations in existing studies introduce several questions about HLC beliefs
and adherence. Even with recent assertions that “different diabetic patients have different
attributional styles” (Morowatisharifabad et al., 2009, p. 42), there are not enough
investigations comparing internality and externality as predictors for prescription drug
use. Contemporary research discusses the role of HLC beliefs in treatment for other
chronic diseases (Atkins & Fallowfield, 2006; Barclay et al., 2007), but studies have not
yet considered if externality and internality operate independently as motivators for
individuals with diabetes or hypertension. Moreover, it is important to consider if there is
an indirect effect from broader psychological constructs like time perspective through
HLC beliefs to adherence. Future studies can incorporate stepwise logistic regression and
path analyses to answer these new questions.
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As noted earlier in the chapter, a second glaring limitation relates to
inconsistencies in data collection methods. Many chronic disease studies on HLC beliefs
employ biological tests to measure drug levels (Macrodimitris & Edner, 2001; O’Hea et
al., 2005; Surgenor et al., 2000), but there have also been a few investigations using selfreports (Patel & Taylor, 2002; Wang et al., 2002). Both methods can be effective means
for collecting data (Atkins & Fallowfield, 2006; Poweles et al., 1998). Some clinical
researchers believe that pill counts and drug levels provide better quantifiable, reliable
precision for making empirically-based contrasts (Atkins & Fallowfield, 2006; Ye et al.,
2012). On the other hand, others assert that objective methods are less than ideal to
complement research designs centered on psychological constructs. Self-report
questionnaires appear uniquely suited to capture small clinically-relevant contrasts in
patient perception for MA research (Patel & Taylor, 2002; Wang et al., 2002). They
typically make research designs less vulnerable to nonresponse by participants, and they
are simpler and less expensive to complete (Wang et al., 2002). Most importantly, selfreports can provide better anonymity so that individuals may honestly describe adherence
or nonadherence behaviors (Guthrie et al., 2009; Guthrie et al., 2013), in comparison to
objective measures that they fear could be reviewed by clinicians or other medical staff.
Conclusions
The 100 million U.S. residents with hypertension or diabetes often struggle with
medication adherence (MA). On average, 65% refer to themselves as nonadherent in
some way, complicating attempts to ascertain the real benefits of medical care to reduce
morbidity and mortality associated with higher risk for stroke and other adverse
cardiovascular events. It is important, therefore, to ask why patients are not taking the
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medications that can effectively manage high blood pressure or diabetes. In answering
this question, there is some evidence that individuals refuse to take medication to avoid
immediate side effects. Others may broadly dismiss the long-term benefits of better
nutrition or lifestyle choices due to the asymptomatic or silent nature of chronic diseases.
Unfortunately, there has been little progress in targeting these barriers based on
demographic and biomedical factors, because they have not been modifiable or even
consistent predictors of medication-taking behaviors.
Clinicians and health service professionals look more to internal phenomenon as
motivators to meet treatment demands. In general, contemporary literature shows that
future time perspectives are better affiliated with health-promoting behaviors than present
ones, yet there is no statistically significant evidence corroborating similar contrasts in
adherence based on time perspective. More conclusive findings show that inconsistent
health beliefs systemically inspire poor lifestyle choices and indirectly contribute to
marginal chronic disease management. The studies into how HLC beliefs influences MA
offer that both externality and internality can motivate patients to complete treatment, but
there remains a need to clarify the comparative benefits using a self-report measure. The
current study implemented a mediational path analysis to determine the degree to which
HLC beliefs add to the identified relationships between psychological constructs and
medication adherence, particularly for people with hypertension or diabetes.
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CHAPTER 3
Methodology
The study investigated the effects of time perspective (TP), health beliefs, and
health locus of control (HLC) beliefs on medication adherence (MA) for participants with
hypertension or diabetes.
Research Questions
The study used meditational path analysis of direct and indirect effects to answer
the following research questions.
Direct Effects
1a. What direct influence does age have on medication adherence among people
with hypertension or diabetes? Contemporary literature suggests that individuals’ drug
use is significantly and positively associated with age (Barclay et al., 2007; Hashmi et al.,
2007). Older patients’ adherence rates can be twice as high as those for younger peers.
Individuals between 70- and 80-years-old can have a 92% success rate in taking
antihypertensive medication (Hashmi et al., 2007).
Hypothesis 1a: I hypothesized that age would have a direct effect on medication
adherence; and I predicted a positive association with the outcome, meaning that older
people would report higher adherence than younger people.
1b. What direct influence does time perspective have on adherence? Literature
signifies that adults with predominantly future outlooks have better exercise habits
(Guthrie et al., 2013; Löckenhoff & Carstensen, 2004), consistent condom use, less
substance abuse (Henson et al., 2006), better psychological well-being, effective
behavioral coping, and higher sense of control (Wills et al., 2001). On the other hand,
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many individuals with increased present perspectives, particularly those whose decisionmaking process is motivated by immediate gratification or a strict belief in predetermined
fate, report more substance abuse, risky sexual practices (Henson et al., 2006), gambling
issues (Hodgins & Engel, 2002), less sense of control, more negative affect, and more use
of angry or maladaptive coping (Wills et al., 2001). Their viewpoints are called presenthedonistic or present-fatalistic time perspectives, respectively. Based on comparing these
findings, the implication is that future perspectives are better affiliated with healthpromoting behaviors than present traits, in contrast to associations for unfavorable
outcomes linked to present time perspectives.
Hypothesis 1b: I hypothesized that future time perspective would have a direct
effect and a positive association with medication adherence, meaning that individuals
with more future outlook would report higher adherence than those with more presenthedonistic perspectives. Additionally, I predicted that present-hedonistic time perspective
would not yield a direct effect on reported drug use.
Indirect Effects
2a. How is time perspective indirectly associated with adherence through
perception of disease severity? In a meta-analysis involving several patient groups,
DiMatteo et al. (2007) present that individuals who refer to their condition as more
serious demonstrate higher MA, even if clinicians identify them as having poorer health.
Those who do not describe the illness as severe may be 22% less likely to be adherent. In
essence, the findings show that the subjective rating of the severity of chronic disease is
just as valuable as a clinician's rating of health status in predicting medication-taking
behavior.
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Hypothesis 2a: I hypothesized that perception of disease severity would mediate
the effect of time perspective on medication adherence differently. I believed that
participants’ future and present-hedonistic outlooks could operate through this health
belief to influence medication adherence indirectly.
2b. How is time perspective indirectly associated with adherence through
perception of susceptibility to future complications? Individuals with elevated perception
of disease susceptibility have higher MA, fewer symptoms, and less illness-related stress
(Broadbent et al., 2011). Mann et al. (2009) infers that people who struggle with
nonadherence often believe that diabetes has few consequences and symptoms.
Hypothesis 2b: I hypothesized that perception of susceptibility to future
complications would mediate the effect of time perspective on medication adherence
differently. I believed that participants’ future and present-hedonistic outlooks could
operate through this health belief to influence medication adherence indirectly.
3. How is time perspective indirectly associated with adherence through internal
locus of control? Several diabetes investigations unanimously indicate that HbA1c
metabolic control improves among people with more internal locus of control
(Macrodimitris & Edner, 2001; O’Hea et al., 2005; Surgenor et al., 2000). According to
Morowatisharifabad et al. (2009), this single HLC belief is the best predictor of
successful adherence, even when individuals believe that fate or chance also influences
health status.
Hypothesis 3: I hypothesized that internal locus of control would mediate the
effect of time perspective on medication adherence; and I predicted a positive association
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between this HLC belief and MA, meaning that time perspective would operate through
elevated internal locus of control to increase drug use.
4. How is time perspective indirectly associated with adherence through external
locus of control? Studies into how health locus of control beliefs influence medication
adherence offer that both externality and internality can motivate a person to complete
treatment (Atkins & Fallowfield, 2006; Barclay et al., 2007).
Hypothesis 4: I hypothesized that external locus of control would mediate the
effect of time perspective on medication adherence differently.
Ethical Compliance
Recruitment
I did not recruit new participants for health behavior protocols.
Selection
I did not select new participants for the study.
Compensation or Incentives
Clinical Trial and Outcomes Branch provided four to five stamps as a minor
incentive when individuals agreed to participate in the health behavior protocol. The
current study did not involve any incentive or compensation, because it no longer
required data collection from research participants.
Potential Risks
There were no foreseeable physical, psychological, social, legal or other risks
associated with using the archival data for statistical reporting. A research nurse ensured
that all hard-copy materials for the study remained in cabinets in a locked office at the
National Institutes of Health. Additionally, the NIAMS Clinical Trial and Outcomes
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Branch maintained electronic versions of the research data on a password-encrypted
database to prevent the harmful use of individuals' information.
Potential Benefits
The principal benefit was a contribution to health behavior theory related to
individuals with chronic diseases. The study illustrated that counselor educators could
provide unique insight into what motivated patients to be more or less adherent to
medical treatment regimens.
Confidentiality
The Clinical Trial and Outcomes Branch safely kept all archival data from health
behavior protocols on an electronic database that was only available to the principal
investigator and research staff. As a research fellow, I maintained professional and ethical
standards of confidentiality in order to preserve the privacy of each participant within the
limits allowed by law.
Measures
Each participant completed a 6-page questionnaire comprised of the Morisky
Medication Adherence Scale (MMAS; Morisky et al., 1986), three subscales of the
Zimbardo Time Perspective Inventory (ZTPI; Zimbardo & Boyd, 1999), two health belief
items, the Multidimensional Health Locus of Control Scale (MHLC; Wallston, Wallston,
& DeVellis, 1978), and demographic items (Appendix).
Medication Adherence
The MMAS has four items assessing the degree of medication adherence. The
questions ask, “Do you ever forget to take your medicine? Are you careless at times
about taking your medicine? When you feel better do you sometimes stop taking your
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medicine? Sometimes if you feel worse when you take the medicine, do you stop taking
it?” People circle a 1 or 0 for yes or no responses, providing a total score up to 4. Then,
responses are reverse coded to produce five categorical levels (0 = completely
nonadherent, 1 = slightly adherent, 2 = adherent on average, 3 = mostly adherent, 4 =
completely adherent). The MMAS has marginal internal consistency with a Cronbach’s
alpha rating of .61 (Morisky et al., 1986). However, the self-report survey is mainstay in
clinical research noting its predictive validity and clinical importance, because of its
sensitivity to discriminate hypertension control (Morisky et al., 1986) from hypertensive
crises (Ross, Walker, & MacLeod, 2004; Shea, Misra, Erhlrich, Field, & Francis, 1992).
Time Perspective
The three ZPTI subscales include 37 items that assess an individual’s orientation
to present-hedonistic, present-fatalistic, and future time perspectives. The presenthedonistic subscale has 15 items that assess being spontaneous, taking risks, and seeking
pleasure (i.e. "Taking risks keeps my life from becoming boring"). The present-fatalistic
subscale has 9 items evaluating the sense that one does not control his or her fate (i.e.
"Often luck pays off better than hard work"). Finally, the future subscale has 13 items
that assess the importance of planning and considering consequences in a participant’s
life (i.e. "I keep working at difficult uninteresting tasks if they will help me get ahead").
People endorse 5-point Likert-type responses ranging from very untrue to very true.
Answers are averaged and reverse coded when necessary so that higher scores up to 5
indicate more of the construct. Cronbach’s alpha ratings show acceptable internal
consistency reliability (present-hedonistic = .79, present-fatalistic = .74, future = .77;
Zimbardo & Boyd, 1999). Additionally, the ZTPI demonstrates construct validity by its
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relationships with risk-taking behaviors and other psychological factors (Apostolidis,
Fieulaine, & Soulė, 2006 Zimbardo & Boyd, 1999; Zimbardo, Keough, & Boyd, 1997).
As previously done in contemporary investigations (Guthrie et al, 2009; Guthrie et al.,
2013; Löckenhoff & Carstensen, 2004; Sansbury et al., 2012), the Clinical Trials and
Outcomes Branch narrowed the ZPTI to three subscales to minimize response burden.
Health Beliefs
The Clinical Trial and Outcomes Branch used items on disease severity and
susceptibility from prior hypertension research exploring expectations that motivate
health-related behaviors (Brown & Segal, 1996). The disease severity item asks, "Which
of the following statements best describes your view of high blood pressure?" People
answer using four categorical levels (1 = a serious problem, 2 = a minor concern, 3 = a
somewhat important problem, 4 = the least of my worries). The susceptibility item is
"High blood pressure can increase a person’s risk of having stroke, heart trouble, or
kidney failure in the future. Which of the following statements best describes how you
think about your high blood pressure?" Individuals responded by endorsing one or four
items (1 = hardly ever think about health and hypertension, 2 = sometimes think about
health and hypertension but do not worry, 3 = often think about how hypertension
affected health and sometimes worry, 4 = worry a lot about how high blood pressure
might affect future health). We reworded the item stems to evaluate perception of severity
and susceptibility related to diabetes in identical ways. Both sets of responses, including
the reverse coded items, served as categorical variables.
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Health Locus of Control
The MHLC consists of 18 items that rate people's expectations that personal
behavior or external influences control their health status. It captures how well
individuals identify with the internal locus of control, chance, and powerful others
subscales. The internal locus of items evaluate how much a person attribute changes in a
medical condition to his or her own actions (i.e. “If I get sick, it is my own behavior
which determines how soon I get well again). The chance items represent the perception
that medical outcomes are determined chance or fate (i.e. “No matter what I do, if I am
going to get sick, I will get sick). Lastly, the powerful others subscale assesses how much
individuals believe external authority figures are more influential in determining if they
are sick or healthy (i.e. “Health professionals control my health”). Individuals endorse
Likert-type responses ranging from 1 to 6 for strongly disagree to strongly agree.
Answers are averaged so that higher ratings up to 6 illustrate more of the construct.
Procedure
Participants completed the 6-page questionnaire and provided information on
demographic characteristics like age, ethnicity, marital status, years of formal education,
gender, and employment. The Clinical Trials and Outcomes Branch entered data from
Fall 2006 to Summer 2010. Research assistants stored the files in password-protected
databases that could only be viewed by them and the director of the Clinical Trials and
Outcomes Branch. In June 2012, I proposed the current study under the supervision of the
same director.
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Statistical Analyses
Preliminary Analyses
My preliminary analyses tested reliability estimates, common factors, sample size
and power estimates, statistical assumptions, trends in demographic information, and the
percentage of missing data.
Reliability estimation. I used Statistical Analysis System Version 9.3 programs
to estimate reliability for continuous scales (SAS Institute, Inc., Cary, NC). I verified
internal consistency among Multidimensional Health Locus of Control Scale (MHLC)
items for internal locus of control (α = 0.67), powerful others beliefs (α = 0.67), and
chance beliefs (α = 0.63; Wallston et al., 1978). I eliminated the third internal locus of
control item, which poorly correlated with remaining ones, to raise the subscale’s alpha
rating from 0.67 to 0.71. Then, I generated an external locus of control variable by
averaging powerful others and chance items, thereby producing a new scale with higher
internal consistency (α = 0.76). Health behavior researchers have applied a similar
method for measuring externality beliefs with the MHLC in the past (Egan, 2009;
Wallston & Wallston, 1981).
Common factors. I explored conceptual and statistical relationships between
external locus of control and time perspectives, given specific concerns about dependence
with the present-fatalistic scale. Several of the present-fatalistic items- namely “It does
not make sense to worry about the future, since there is nothing that I can do about it
anyway” and “Often luck pays off better than hard work”- appeared very similar to
externality items like “No matter what I do, I’m likely to get sick.” Early theorists and
recent investigators alike have noted the conceptual link between external locus of
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control and present-fatalistic time perspective. The two psychological constructs mutually
motivate the prediction of failures or successes, negativity related to the potential of
personal action altering life events (Haghighatgoo, Ali Besharat, & Zebardast, 2011),
expectations (Haghighatgoo et al., 2011; Lewin, 1951), and competency and contingency
beliefs (Shell & Husman, 2001).
Through subsequent analysis, I discovered statistical evidence that externality
beliefs and present-fatalistic outlook measured some underlying psychological factor. My
common factor analysis estimated the total final communality to be 0.75, so I determined
that the two variables possessed an extremely high degree of shared variance across their
21 items. Additionally, linear regression verified that participants’ external loci of control
significantly varied based on time perspective (F = 8.43, p < .0001); present-fatalistic
outlook predicted differences in this health HLC belief (t = 3.64, p < 0.001), where
present-hedonistic outlook (t = -0.16; p = 0.87) and future outlook (t = -0.50, p = 0.62)
did not. Given conceptual and statistical support, I elected to drop the present-fatalistic
time perspective items in favor of external locus of control ones. I believed that the
remaining variable could encompass individuals' attitudes toward influencing health
outcomes and overall life experiences.
Sample size and power estimates. Statistical power analyses were conducted to
determine appropriate sample sizes for identifying significant results, should they exist,
and for avoiding misleading associations (Balkin & Sheperis, 2011). An a priori test
using G*Power 3.1 software (Faul, Erdfelder, Lang, & Buchner, 2007) determined that I
needed a minimum of 55 participants to detect a total model effect at a power of .80, if
such statistically significant result existed and given an alpha of .05. Furthermore,
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contemporary studies often follow a 1:10 ratio of sample size to the number of
parameters in structural equation modeling (Kline, 2005). Given that 79 individuals
provided information on eight parameters, I considered that ratio acceptable for
conducting the current investigation. A post hoc analysis further indicated that mediation
path analysis would achieve statistical power at the .88 significance level. Overall, these
preliminary findings demonstrated that the primary analyses could afford me acceptable
and high statistical power, given that contemporary standards require at least an 0.80
significance level for a large effect (Cohen, 1988), to make accurate observations
regarding psychological factors associated with medication adherence.
Statistical assumptions. I judged that it was inappropriate to evaluate many
assumptions associated with continuous scales for the categorical variables. However, I
used SAS programs to confirm the normal distribution of responses to continuous scales
and to test multicollinearity between all items (SAS Institute, Inc., Cary, NC). I was
especially concerned that certain predictor variables, time perspectives and health locus
of control beliefs, were somewhat similar in theory. I calculated variance inflation factors
(VIF; Table 2). The results indicated that VIF ranged between 1.53 and 5.28 for most
variables; however, powerful others items highly correlated with the chance and external
locus of control items.
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Table 2
Evaluation of Variance Inflation Factors (VIF) for Predictor Variables
Variable

VIF

Present-hedonistic
Present-fatalistic
Future
Internal locus of control
External locus of control
Chance
Powerful others

2.03
2.95
1.91
1.53
4.25
5.28
*

*locpower = 2 (locext - locchance)

In the next step, I used a stepwise regression for generalized linear models, with
0.25 as the variable selection criterion and 0.15 as the staying criterion, to generate a final
set of predictor variables. The outcomes demonstrated that likelihood ratio test would
perform well if I divided HLC beliefs into internal locus of control and external locus of
control, so I elected to exclude chance and powerful others effects from the total model.
Participant characteristics. The final group of 79 individuals consisted of 66
with a single diagnosis and 13 with co-occurring hypertension and diabetes. The
participants were generally older minorities with some college education (Table 3). The
group included slightly more males (54.43%) than females (45.47%). In comparison, the
City of Martinsburg has reported that 63.30% of its 17,227 residents were 18- to 64years-old; 22.50% of its residents were racial or ethnic minorities; 48.80% were male and
51.20% were female (U.S. Census Bureau, 2010). The demographic information
illustrated that the participants represented a more multicultural sample than residents
living in Martinsburg.
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Table 3
Means, Standard Errors, and Prevalence Percentages for
Participant Characteristics
Mean ± SE/
Prevalence (%)
Variable
Age (years)
Years of formal education
Time perspective
Present-hedonistic
Present-fatalistic
Future
Internal locus of control
External locus of control
Gender
Women
Men
Racial/ethnic background
White (non-Hispanic origin)
Black
Asian or Pacific Islander
Hispanic
Other

58.84 ± 1.57
12.83 ± 0.27
3.17 ± 0.06
2.71 ± 0.10
3.66 ± 0.07
4.57 ± 0.09
3.27 ± 0.09
45.57%
54.43%
40.51%
37.97%
1.27%
3.80%
16.46%

Missing data. People answered every item on medication adherence, time
perspective, and health locus of control beliefs. Some in the final group failed to answer
questions about health beliefs, however. Twenty-four people did not provide 12 or
15.19% of responses for perception of disease severity and 12 or 15.19% of responses for
perception of susceptibility to future complications. I recoded the 24 missing values in
the dataset from "." to -999, because Muthén and Muthén (1998-2010) have
recommended this step for completing path analysis in Mplus. Ensuing tests corrected for
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recoded data to maximize use of all available data by determining maximum likelihood in
latent response variables (Muthén, Jo, & Brown, 2003).
Primary Analysis
I used primary analyses to conduct descriptive statistics, path analysis and total
model fit, and structural modeling. I considered eight variables in the total model:
medication adherence as a criterion variable; present-hedonistic and future time
perspectives as predictor variables; perceived disease severity, perceived susceptibility to
future complications, external locus of control, and internal locus of control as mediators;
and age as a covarying predictor variable.
Descriptive statistics. I employed central tendency and correlation procedures to
gather descriptive statistics on participants’ information. For example, I calculated group
means for time perspective and health locus of control beliefs, because they were
continuous variables, whereas I found group mode for health beliefs and medication
adherence, because they were categorical ones. Correlation analyses allowed me to
determine statistical relationships between all the variables.
Path analysis and total model fit. I chose to do path analysis for several reasons.
First, it enabled me to examine structural relationships between nonnumeric categories of
psychological factors and beliefs (Yu, 2002); moreover, it simultaneously examined
direct effects and indirect effects of continuous predictor variables and categorical
mediators on categorical outcomes. I also selected path analysis because it enabled me to
determine the relevance of psychological constructs on medication adherence by
calculating total model fit, which compared the hypothesized total model with a restricted
baseline model (Muthén, 1998-2004; Yu, 2002). To assess goodness-of-fit, I ran several
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tests, including the chi-square statistic and root mean square error of approximation
(RMSEA) estimate, with an estimates below 0.08 and probability above 0.05 as criteria
for assessing goodness-of-fit between the hypothesized model and null model. The
equation for RMSEA was

v((χ2/(n*d)) - (1/n))*v(g),

where d represented degrees of freedom; n represented total sample size; χ2 represented
the chi-square statistic; and g represented the number of groups (Muthén, 1998-2004).
I also considered two incremental fit indices- comparative fit index (CFI) and
Tucker-Lewis Index (TLI) - with 0.95 to 0.99 repeating as additional criteria.
Contemporary writers have recognized these conventional cut-offs for preventing Type II
error with sample sizes smaller than 100 (Hu & Betler, 1999; Muthén, 1998-2004; Yu,
2002). The equations were

TLI = (χ2B/dfB - χ2H0/dfH0) / ( χ2B/dfB – 1) and
CFI = 1 – max (χ2H0 - dfH0,0)/ max (χ2H0 - dfH0, χ2B - dfB, 0),

where χ2B represented the chi-square statistic for the baseline model; dfB represented
degrees of freedom for the baseline model; χ2H0 represented the chi-square statistic for the
hypothesized model; and dfH0 represented the degrees of freedom for total model
(Muthén, 1998-2004).
Structural modeling. I generated mediation models with several procedures
divided into ANALYSIS, and MODEL commands (Muthén & Muthén, 1998-2010).

53

ANALYSIS command. Four ANALYSIS procedures established the technical
guidelines for the path analysis:
ANALYSIS:
ESTIMATOR = WLSMV;
PARAMETERIZATION = THETA;
!ITERATIONS = 5000;
!BOOTSTRAP = 1000;
To start, I calculated a diagonal weighted matrix with standard errors and chi-square
statistics adjusted for means and variance in order to determine weighted least square
parameter estimates (WLSMV) with the DIFFTEST command. This procedure allowed
me to find probit regression coefficients or probability for likelihood of categorical
outcomes (Muthén & Muthén, 1998-2010), in essence. In the next step, I selected Theta
parameterization to set variance and residual variance between parameters at one for the
main pathways (Muthén & Muthén, 1998-2010). My iterations procedure specified 5000
as the maximum number of draws to Quasi-Newton algorithms for model estimates.
Finally, I chose the bootstrap procedure, in combination with the confidence interval
option in the OUTPUT command, in order to formulate bootstrap standard errors and to
adjust confidence intervals for potential bias; and I used it with the model indirect option
to correct for any potential bias in mediator parameters (Muthén & Muthén, 1998-2010).
MODEL command. The procedures for the MODEL command defined the
predicted relationships for direct effects and indirect effects:
MODEL:
adherence_htndom ON age tphedon tpfuture locint locext susc_htndom sev_htndom;
locint locext ON tphedon tpfuture age;
susc_htndom sev_htndom ON tphedon tpfuture age;
tphedon tpfuture ON age;
tphedon WITH tpfuture;
locint WITH locext;
sev_htndom WITH susc_htndom;
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MODEL indirect:
adherence_htndom IND tphedon;
adherence_htndom IND tpfuture;
Specifically, I used the ON or WITH statements to determine how well parameters
regressed on or correlated to one another, respectively; and I employed the IND option to
identify estimated indirect effects (Muthén & Muthén, 1998-2010).
OUTPUT command. I described which procedures I wanted to interpret path
analysis with the following OUTPUT command:
OUTPUT:
SAMPSTAT;
PATTERNS;
RES;
MOD (3.84);
TECH1;
TECH5;
!TECH8;
!CINTERVAL (bcboot);
Most notably, I requested the SAMPSTAT option to acquire sample thresholds, sample
probit regression coefficients, and probit residual correlations, given that the model had
ordered categorical variables and covariates (Muthén & Muthén, 1998-2010). I also
selected the PATTERNS option to verify where participants omitted answers on the
health behavior protocols; the summary of missing data confirmed that several people did
not complete items on health beliefs. Next, I chose the TECH1 procedure to request
arrays with starting values and parameter specifications. Lastly, I chose the CINTERVAL
option, in combination with the bootstrap option in the ANALYSIS command, in order to
formulate bootstrap standard errors and to adjust confidence intervals for potential bias.
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CHAPTER 4
Results
In this fourth chapter, I comprehensively state the results of mediational path
analyses to answer six research questions. I initially describe how participant
characteristics cluster in regard to demographics, psychological constructs, and
medication adherence. In the remaining sections, I explain pathways from identified
predictors to reported categories of prescribed drug use, ranging from completely
nonadherent to completely adherent; and I delineate findings from direct and indirect
effect tests on the associations between psychological constructs and the ordinal
categorical outcome.
Participant Characteristics
In terms of demographics, the 79 participants consisted of 66 with a single
diagnosis and 13 with co-occurring hypertension and diabetes. Their ages varied from 19to 86-years-old (M = 58.84 ± 1.57, Table 3). Individuals reported having formal
education from middle school up to advanced graduate degrees (M = 12.83 ± 0.27). On
average, the group included slightly more men (n = 43, 54%) than women (n = 36, 45%).
People represented diverse racial and ethnic backgrounds- including non-Hispanic White
origin (n = 32, 41%), Black or African American origin (n = 31, 40%), Hispanic origin (n
= 3, 4%), and Asian or Pacific Islander origin (n = 1, 1%), in order of prevalence. The
remaining participants who selected other presumably identified with multiple racial or
ethnic backgrounds (n = 12, 17%). To summarize, the majority of individuals were older
minority men with high school diplomas or general education development certification
and some college education.
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People provided an array of responses pertaining to psychological constructs and
reported drug use. According to analysis of continuous variables for group trends, they
reported moderate future time perspectives (M = 3.66 ± 0.07) and slightly less presenthedonistic time perspective (M = 3.17 ± 0.06) on ZPTI subscales scores ranging from 0 to
5. They also described themselves as having more internal locus of control (M = 4.57 ±
0.09) than external locus of control (M = 3.27 ± 0.09) on MHLC subscales scores ranging
from 0 to 6.
Individuals showed clear patterns on categorical scales related to health beliefs
and medication adherences (Table 4). As many as 58% believed that hypertension was a
serious problem; 77%, an even larger percentage, believed that diabetes was a serious
problem in their lives. Smaller groups, 13% and 39%, expressed a great deal of worry
about future complications. The majority of participants, 29% or 48% respectively, said
they were mostly adherent or completely adherent to antihypertensive regimens.
However, 23% referred to themselves as adherent on average or less often. People
reported similar use of antidiabetic medications- 30% and 39%, in order, said they were
mostly adherent or completely adherent to regimens. Overall, all responses pertaining to
antihypertensive and antidiabetic drug use shared a covariance of 0.77, so I determined
that the outcomes could be collapsed onto the single main pathway for interpreting
results.
Correlation analyses further demonstrated statistically significant relationships
between medication adherence and health beliefs in the main pathways (Table 5). Two
Spearman regression coefficients, 0.44 and 0.40, indicated that reported drug use
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Table 4
Percentages for Psychological Constructs and Medication Adherence
Variable

Prevalence (%)

Perception of hypertension severity
Least of worries
A minor concern
A somewhat important problem
A serious problem
Perception of susceptibility to hypertension complications
Hardly ever thought about
Sometimes thought about with no worry
Often thought about with worry
Worried about a lot
Antihypertensive medication adherence
Completely nonadherent
Slightly adherent
Adherent on average
Mostly adherent
Completely adherent
Perception of diabetes severity
Least of worries
A minor concern
A somewhat important problem
A serious problem
Perception of susceptibility to diabetes complications
Hardly ever thought about
Sometimes thought about with no worry
Often thought about with worry
Worried about a lot
Antidiabetic medication adherence
Completely nonadherent
Slightly adherent
Adherent on average
Mostly adherent
Completely adherent

2.99%
8.96%
29.85%
58.21%
17.91%
29.85%
32.84%
19.40%
9.62%
1.92%
11.54%
28.85%
48.08%
3.23%
3.23%
16.13%
77.42%
6.45%
22.58%
32.26%
38.71%
13.04%
4.35%
13.04%
30.43%
39.13%

increased with perceived disease severity and susceptibility to future complications.
Correlations did not identify how adherence regressed on other psychological constructs.
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Table 5
Spearman Correlation Coefficients Between Predictors and Medication Adherence

Variable

Age

Age
Present-hedonistic
0.22
Future
-0.09
Disease severity
0.05
Susceptibility
0.07
Internal locus of control 0.30*
External locus of control 0.19
Medication adherence
0.11

Presenthedonistic

Future

Disease
Internal
severity Susceptibility control

-0.31*
0.01
-0.08
-0.2
0.13
0.12

-0.01
0.19
0.16
-0.34*
-0.02

0.63**
-0.09
-0.13
0.44**

0.01
-0.14
0.40**

External
control

0.12
0.19

0.16

* p < .05. ** p < .001.

Lastly, analysis of categorical responses also suggested several trends between
psychological constructs and prescription drug use in the main pathways (Table 6). To
start, people who reported higher adherence to drugs for hypertension and diabetes
typically had elevated future outlook and internal locus of control. The participants with
more present-hedonistic outlooks and external locus of control demonstrated unclear
patterns in medication adherence, in comparison. In addition, findings supported the
benefit of internal locus of control over external locus of control on health beliefs. The
former's influence seemed superior when contrasting means for perception of disease
severity and susceptibility to future complications across the highest levels. A similar
contrast of health beliefs indicated that future time perspective promoted perception of
disease severity and susceptibility to future complications across the highest levels, where
these psychological constructs declined based on present-hedonistic time perspective.
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Table 6
Mean ± SE for Health Beliefs and Medication Adherence for All Time Perspectives and Health Locus of Control Beliefs

Variable

Presenthedonistic

Future

Internal locus
of control

External locus
of control

Perception of disease severity
Least of worries
A minor problem
A somewhat important problem
A serious problem

3.97 ± 0.37
3.16 ± 0.19
3.29 ± 0.10
3.14 ± 0.09

3.65 ± 0.04
3.74 ± 0.15
3.52 ± 0.16
3.67 ± 0.11

5.10 ± 0.90
4.27 ± 0.28
4.56 ± 0.18
4.51 ± 0.15

4.48 ± 0.68
3.26 ± 0.27
3.21 ± 0.19
3.19 ± 0.14

Perceived susceptibility to hypertension complications
Hardly ever thought about
Sometimes thought about with no worry
Often thought about with worry
Worried about a lot

3.18 ± 0.22
3.40 ± 0.10
3.24 ± 0.11
2.90 ± 0.11

3.44 ± 0.12
3.37 ± 0.13
3.78 ± 0.14
3.94 ± 0.15

4.38 ± 0.40
4.32 ± 0.14
4.62 ± 0.18
4.80 ± 0.17

3.39 ± 0.30
3.27 ± 0.20
3.18 ± 0.17
3.16 ± 0.19

Medication adherence
Completely nonadherent
Slightly adherent
Adherent on average
Mostly adherent
Completely adherent

3.08 ± 0.21
1.13 ± N/A
3.04 ± 0.22
3.18 ± 0.10
3.33 ± 0.12

3.15 ± 0.29
2.08 ± N/A
3.71 ± 0.39
3.96 ± 0.11
3.56 ± 0.13

3.72 ± 0.31
1.00 ± N/A
4.27 ± 0.26
4.51 ± 0.19
4.93 ± 0.14

3.67 ± 0.45
1.08 ± N/A
3.33 ± 0.36
2.98 ± 0.21
3.53 ± 0.16

*N/A indicates no standard error where only a single participant provided information.
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Total Model Fit
I calculated probit regression coefficients to determine the effect of predictors’
changes on the probability of outcome change in the total model fit (Figure 2), which was
the statistical comparison of psychological pathways and a more restricted baseline
model in their ability to predict participants' medication adherence. Among fit indices, a
chi-square test yielded a statistically significant result in favor of the hypothesized model
(χ2 = 148.26, df = 31, p < 0.001); the root mean square error of approximation exceeded
the recommended 0.08 criterion (RMSEA estimate = 0.22, 90% CI [0.18, 0.26], p <
0.001); The comparative fit index (CFI) and Tucker-Lewis index (TLI), 0.17 and -0.47
respectively, suggested poorer fit for the hypothesized model because both were
considerably below the 0.95 criteria (Hu & Betler, 1999; Muthén, 1998-2004; Yu, 2002).
Given the chi-square outcome, I determined that omnibus test collectively showed that
the psychological pathways exhibited some influence in observed medication adherence,
but the path analysis required further manipulation to determine the best categorical data
model of direct and indirect effects between variables (Muthén & Muthén, 1998-2011). I
translated the categorical data model to probabilities or reporting different adherence
levels according to estimated thresholds. Here, I also interpreted results in terms of
standard deviations in the underlying latent variable, because probability change differed
depending on how participant information compared to the overall distribution of
reported drug use.
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Presenthedonistic

-0.25

Susceptibility

-0.35*

0.30*

0.28

0.01

0.24
0.30*

Disease
Severity

-0.07*
0.17*

Age

-0.12

Adherence

0.03*
0.02
0.51*
0.77**
-0.01
-0.20

Future

Internal locus
of control

0.44**
0.20**
-0.28*

-0.08

External locus
of control

Figure 2. Path diagram of the total model. * p < .05. ** p < .001. Significant paths shown with dashes.
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Direct effects
Research question 1a. What direct influence does age have on medication
adherence among people with hypertension or diabetes? I hypothesized that age would
have a direct effect on medication adherence; and I predicted a positive association with
the outcome, meaning that older people would report higher adherence than younger
people. The direct effect test for the age covariate supported both assumptions (Figure 3.
unstandardized parameter estimate = 0.03, SE = 0.01, p = 0.01). An increase in age by a
single year predicted a 0.03 standard deviation change in the probability of people being
more adherent to prescribed medication. On average, individuals' estimated drug use
improved by 0.30 with every additional ten years.

Adherence

Age

Figure 3. Path diagram of the direct effect of age on medication adherence. *p < .05.
**p <.001. Significant path shown with dashes.

Research question 1b. What direct influence does time perspective have on
adherence? I hypothesized that future time perspective would have a direct effect and a
positive association with medication adherence, meaning that individuals with more
future outlook would report higher adherence than those with more present-hedonistic
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perspectives. Additionally, I predicted that present-hedonistic time perspective would not yield a direct effect on reported drug
use. The direct effect test failed to support either assumption about the strength or direction of associations (Figure 4. presenthedonistic time perspective unstandardized parameter estimate = 0.28, SE = 0.29, p = 0.33; future time perspective
unstandardized parameter estimate = -0.20, SE = 0.26, p = 0.45).

Presenthedonistic
0.01

0.28

0.03*

Age

- 0.01

Adherence

- 0.20
Future

Figure 4. Path diagram of the direct effect of time perspective on medication adherence. * p < .05. ** p < .001. Significant
path shown with dashes.
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Despite the nonsignificant results, an increase in present-hedonistic outlook by a single
unit on the 0 to 5 scale contributed to a 0.28 standard deviation change in the probability
of individuals having higher medication adherence, whereas an increase in future time
perspective by a single unit on the 0 to 5 scale contributed to a 0.20 standard deviation
change in the probability of individuals having lower medication adherence.
In addition to the two previous research questions, I calculated direct effects from
all potential mediators on the ordered categorical outcome. Only one of these variables,
internal locus of control, had a statistically significant relationship with adherence (Figure
5. unstandardized parameter estimate = 0.77, SE = 0.21, p < 0.001). An increase in this
health locus of control belief by a single unit on the 0 to 6 scale contributed to a 0.77
standard deviation change in the probability of individuals having higher medication
adherence.

Internal
locus of
control

0.77**

Adherence

Figure 5. Path diagram of the direct effect of internal locus of control on medication
adherence. *p < .05. **p < .001. Significant path shown with dashes.

Conversely, among the nonsignificant results, an increase in external locus of
control by a single unit on the 0 to 6 scale contributed to a 0.08 standard deviation change
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in the probability of individuals saying they used prescribed medications less often (SE =
0.20, p = 0.68); an increase in perception of disease severity by a single unit on the 0 to 4
scale contributed to a 0.12 standard deviation change in the probability of individuals
reporting better adherence (SE = 0.26, p = 0.64); and an increase in perception of
susceptibility to future complications by a single unit on the 0 to 4 scale contributed to a
0.24 standard deviation change in the probability of individuals saying they used the
prescribed medications less often (SE = 0.20, p = 0.23).
Indirect Effects
Research question 2a. How is time perspective indirectly associated with
adherence through perception of disease severity? I hypothesized that perception of
disease severity would mediate the effect of time perspective on medication adherence
differently. I also believed that participants’ future and present-hedonistic outlooks could
operate through this health belief to influence medication adherence indirectly. Specific
indirect effect tests were not in favor of either assumptions (Figure 6. present-hedonistic
time perspective  perceived disease severity  medication adherence, unstandardized
parameter estimate = 0.04, SE = 0.10, p = 0.66; future time perspective  perceived
disease severity  medication adherence, unstandardized parameter estimate = 0.00, SE
= 0.02, p = 0.89).
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Presenthedonistic
0.04
Disease
severity
Adherence
0.00

Future

Figure 6. Path diagram of the indirect effect of time perspective on medication adherence through perceived disease
severity. *p < .05. **p < .001.

Research question 2b. How is time perspective indirectly associated with adherence through perception of
susceptibility to future complications? I hypothesized that perception of susceptibility to future complications would mediate
the effect of time perspective on medication adherence differently. I believed that participants’ future and present-hedonistic
outlooks could operate through this health belief to influence medication adherence indirectly. Specific indirect effect tests
failed to support either hypotheses (Figure 7. present-hedonistic time perspective  perceived susceptibility  medication
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adherence, unstandardized parameter estimate = -0.06, SE = 0.06, p = 0.29; future time perspective  perceived susceptibility
.
 medication adherence,
unstandardized parameter estimate = 0.13, SE = 0.11, p = 0.26).

Presenthedonistic
-0.06

Susceptibility

Adherence

0.13

Future

Figure 7. Path diagram of the specific indirect effect of time perspective on medication adherence through perceived
susceptibility to future complications. *p < .05. .**p < .001.
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Research question 3. How is time perspective indirectly associated with adherence through internal locus of control?
I hypothesized that internal locus of control would mediate the effect of time perspective on medication adherence; and I
predicted a positive association between this HLC belief and MA, meaning that time perspective would operate through
elevated internal locus of control to increase drug use. Among the results, specific indirect effect tests indicated that internal
locus of control mediated the effect of time perspective on adherence (Figure 8. present-hedonistic time perspective  internal

Presenthedonistic

0.13*

Internal locus
of control

Adherence

0.34*

Future

Figure 8. Path Diagram of the specific indirect effect of time perspective on medication adherence through internal
locus of control. *p < .05. **p < .001. Significant paths shown with dashes.
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locus of control  medication adherence, unstandardized parameter estimate = 0.13, SE
= 0.06, p = 0.03; future time perspective  internal locus of control  medication
adherence, unstandardized parameter estimate = 0.34, SE = 0.13, p = 0.01). The findings
showed that both time perspectives operated through the mediator to improve reported
drug use. In combination with the indirect effect from internal locus of control, an
increase in present-hedonistic outlook on a 0 to 5 scale predicted a 0.13 standard
deviation change in the probability of people being more adherent to prescribed
medication, where an increase in future outlook predicted a 0.34 standard deviation
change.
Research question 4. How is time perspective indirectly associated with
adherence through external locus of control? I hypothesized that external locus of control
would mediate the effect of time perspective on medication adherence differently.
Specific indirect effect tests determined that external locus of control did not mediate the
effect of time perspective on adherence (Figure 9. present-hedonistic time perspective 
external locus of control  medication adherence, unstandardized parameter estimate = 0.03, SE = 0.06, p = 0.67; future time perspective  external locus of control 
medication adherence, unstandardized parameter estimate = 0.02, SE = 0.06, p = 0.69).
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Presenthedonistic
-0.03
External locus
of control

Adherence

0.02

Future

Figure 9. Path diagram of the specific indirect effect of time perspective on medication adherence through internal
locus of control. *p < .05. **p < .001.
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CHAPTER 5
Conclusion
In this final chapter, I discuss how the categorical data modeling supported or
failed to support the six research questions. I also elaborate on how findings contribute
implications for theory and practice as they pertain to health behavior counseling. To
conclude, I share the study's limitations and future directions to advance medication
adherence studies.
Discussion
The current study provided the first statistical evidence of the strength and
direction of simultaneous associations between time perspective, health beliefs, health
locus of control (HLC) beliefs, and medication adherence (MA). Most notably, the
analysis did not detect any direct effect from either future or present-hedonistic time
perspectives, where older age and greater internal locus of control predicted drug use.
Internal locus of control outperformed all other predictors- its magnitude suggested the
largest increase in likely change from adherent on average to completely adherent.
Among indirect effect tests, participants' internal locus of control also mediated the effect
of time perspective on adherence. The findings showed that both present-hedonistic and
future orientation operated through the mediator to boost reported drug use.
Implications for Theory
The findings further validate existing knowledge that adherence improves as
patients get older (Barclay et al., 2007; Hashmi et al., 2007). Among people with
hypertension or diabetes, an increase in age by a single year may bring a 0.03 change in
the likelihood of being more adherent to prescribed medication; and, moreover, drug use
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can rise from adherent on average to completely adherent with every additional ten
years. The observed increase in adherence corresponds with prior evidence that older
patients’ adherence rates can be twice as high as those for their younger peers, especially
considering a 92% compliance rate for individuals between 70- and 80-years-old
(Hashmi et al., 2007). Two implications emerge from this finding: older adults can be
less at-risk for poor adherence; and younger adults can be more at-risk for poor
adherence. It is possible that MA is better in older individuals because they have prior
medical conditions that have warranted medication use and helped to condition adherence
behavior. Therefore, older people's medication adherence could be attributed to making
decisions and goals that effectively enable this habit, perhaps even when controlling for
complications associated with comorbidity or polypharmaceutical regimens. Younger
individuals, in comparison, can have less concern for mortality or future consequences;
and they may not have medical histories requiring prolonged drug use.
A direct effect test failed to support the hypothesis that future or presenthedonistic time perspectives singularly impact medication adherence. The findings do not
corroborate evidence that future outlook is better affiliated with health-promoting
behaviors than present outlooks. It is possible that the current study does not support any
direct effect, particularly a positive association with future time perspective (Sansbury et
al., 2012), due to the introduction of internal locus of control as a mediator.
Indirect effect tests indicated that medication adherence can increase for a person
with either elevated future orientation or present-hedonistic orientation if he or she
develops more internal locus of control. According to comparison of path diagrams for
the total model and specific effects, the mediator decreases the magnitude of the present-
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hedonistic time perspective's effect from 0.28 to 0.13, yet it makes the influence from the
distal psychological construct statistically significant. An increase in present-hedonistic
orientation by a single unit operates through internal locus of control for a 0.13 change in
the likelihood of individuals being more adherent to prescribed medication. Similarly,
another implication is that the mediator alters the direction of the association between
future time perspective and reported drug use from -0.20 to 0.34 for people with
hypertension or diabetes, and it makes the influence from the distal psychological
construct statistically significant, here again. An increase in future time perspective by a
single unit operates through the HLC belief for a 0.34 change in the likelihood of being
more adherent to drugs. The findings support existing evidence that internal locus of
control is a superior predictor of future drug use (Macrodimitris & Edner, 2001;
Morowatisharifabad et al., 2009; O’Hea et al., 2005; Surgenor et al., 2000).
Indirect effect tests also yielded several nonsignificant results related to mediation
from health beliefs and external locus of control. The results do not substantiate evidence
from a recent meta-analysis that individuals who refer to chronic diseases as severe are
on average 22% less likely to be completely adherent (DiMatteo et al., 2007). They also
fail to support that elevated perception of susceptibility to future complications promotes
higher MA. Lastly, he current study does provide some indication in favor of growing
evidence that internality and externality beliefs can simultaneously affect health
behaviors (Atkins & Fallowfield, 2006; Barclay et al., 2007), yet the findings
demonstrate that external locus of control can be less influential than internal locus of
control in predicting drug use for people with hypertension and diabetes. According to
descriptive statistics, people who reported higher adherence to drugs for hypertension and
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diabetes typically have elevated internal locus of control, but it still unclear how external
locus of control directly contributed to people's medication adherence. More research is
needed to determine significant structural relationships between perception of disease
severity, perception of future complications related to chronic disease, external locus of
control, and prescription drug use.
Implications for Counseling Practice
Another major implication is that behavioral counselors may apply new
knowledge of these psychological pathways so people with diabetes or hypertension can
better manage symptoms and even complications brought on by treatment. Doing so will
likely impact medication adherence and even reduce macro-level outcomes like lost days
at work or school (Lurie et al., 2000), fewer available appointments with primary care
providers (Bender & Rand, 2004), unnecessary healthcare expenses (Pai & Drotar, 2010),
and avoidable deaths each year (Takiya et al., 2004), as a consequence. The findings
validate other existing efforts to accomplish these goals by investigating how internal
phenomena motivate health behaviors over time (Broadbent et al., 2011; DiMatteo et al.,
2007; Mann et al., 2009), especially by offering that time perspective operates through
internal locus of control to boost MA. Counselors can partner with the medical
community to develop individual and structural interventions that target patient health
behaviors with the new knowledge.
To start at the individual level, there is considerable literature suggesting that
training health professionals in both cognitive-behavioral techniques (Graves, Roberts,
Rapoff, & Boyer, 2010; Grey, Boland, Davidson, Li & Tamborlane, 2000; Payne, 2012)
and motivational interviewing strategies (van Eijk-Hustings, Daemen, Schaper, &
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Vrijhoef, 2011; Hood, 2010; Zwinker et al., 2012) can improve medication adherence.
Cognitive-behavioral theory (Beck, 1993, 1999) proposes that learned thoughts direct
feelings and behaviors related to chronic disease management. The results offer that a
person's cognitions surrounding internal locus of control and time perspective play
integral roles in chronic disease management. Whether he or she has largely future or
present-hedonistic outlooks, one implication is that counselors can target his or her
beliefs about altering health status based on personal action to boost use of prescription
drugs. Intrinsically-motivated patients will likely respond well to more preventative
techniques like brief psychoeducation and technology-based skill courses (Duff &
Latchford, 2010). Behavioral counselors can train healthcare providers, in the event that
there are small challenges to adherence, to put these individuals back on course with
behavioral strategies or contingency planning. The long list of clinical techniques
includes self-monitoring through journaling or homework assignments, Socratic
questioning about treatment challenges, role play, rehearsing positive self-talk, and
thought stopping. According to small case studies and meta-analyses, using such
cognitive behavioral interventions allows patients to practice coping skills to handle
general life stressors and even conflicts specific to chronic disease management (Hood,
2010; Payne, 2012); it can also empower them and family members to unlearn unhealthy
patterns through techniques that have long-term usefulness and cost benefit (Graves et al.,
2010).
It appears that motivational interviewing can be another platform for targeting
medication adherence through time perspective and internal locus of control. This
strategy, unlike more directive cognitive-behavioral techniques, seems uniquely
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appropriate to treat patients with less readiness to take prescribed drugs for diabetes and
hypertension. The current study indicates that difficulties with completing drug regimens
are reality for over 50% of people. An implication is that they can benefit by working
through disbelief that personal action will change health status. Along these lines,
motivational interviewing seems better suited for the individuals who must resolve
ambivalence toward nonadherence without feeling misjudged or rejected by health
professionals (Borrelli, Riekert, Weinstein, & Rather, 2007; Miller & Rollinick, 2002).
The emphasis would not be on confronting an individual about his or her time
perspectives or internal locus of control. Instead, a clinician uses person-centered
techniques to promote change talk and to build a therapeutic alliance that serve as
powerful levers for building new intrinsic motivation, as a result.
Health behavior counselors can elicit change talk with six major componentsrolling with resistance, expressing empathy, avoiding arguments, developing discrepancy,
promoting self-efficacy, supporting behavior change in the patient-provider alliance
(Miller & Rollnick, 2002). The first and three final skills especially resonate with the
current findings. For example, rolling with resistance involves acknowledging and
normalizing when patients have intrinsic and perhaps practical barriers to taking
prescribed drugs (Krishna-Pillai, 2012). Open dialogue about natural resistance or
defensiveness will likely review repetitive and nonreoccurring life experiences associated
with how they formed related points of view. Notably, the findings imply that a person's
memories inform internal locus of control and time perspective. The next skill,
developing discrepancy, is critical for targeting poor adherence (Krishna-Pillai, 2012).
The emphasis is on identifying conflict between values (e.g., importance of raising a
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family) and behavior (e.g. not taking medication that will prevent morbidity and
mortality). Recognizing such discrepancy generally compels an individual's efforts to
move toward treatment goals. Next, promoting self-efficacy involves celebrating minor
successes as people approximate intended health behaviors (Miller & Rollinick, 2002).
There is consistent evidence that the reinforcement fosters new confidence that
encourages internal locus of control (Brodie et al., 2007; Pinto et al., 2005; Schmaling et
al., 2001). Finally, the effective transition from contemplative change talk to better
medication-taking behaviors relies on a supportive climate in the patient-provider
relationship (Miller & Rollnick, 2002). Health professionals work as collaborators in
visits, instead of experts in patients' lives, in order to bolster faith in personal ability to
overcome barriers to adherence; and, by default, they strengthen individuals' autonomy
related to make healthy choices at home. Overall, meta-analyses of contemporary studies
suggest that these tenets of motivational interviewing fortify internal locus of control
(Burke et al, 2004; Rubak et al., 2005; Thompson, 2011), which this study identifies as a
crucial psychological pathway for interpreting drug use.
Implications for Counselor Education and Training
The findings provide insights into why one out of every two people with chronic
diseases struggle with drug regimens. A staggering reality is that medical risks and costs
affiliated with hypertension and diabetes will only continue to increase without
comprehensive strategies to improve their adherence (DiMatteo et al., 2012). In the spirit
of partnering with the medical community to decrease these burdens, health behavior
counselors possess a collection of skills to develop structural interventions that move the
discussed implications into more effective practice in the healthcare system. They can
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especially contribute expertise in necessary training and evaluation to do so. Through
training, clinicians and physicians serving individuals with higher nonadherence can start
a more open and nonjudgmental dialogue about health behaviors (Zwikkler et al., 2012).
They will likely gain better leverage on resistance to medication adherence if they use
motivational interviewing. Health behavior counselors may introduce the needed skills to
health professionals in as little as a single hour-long workshop, and they can revisit
intervention strategies through basic or in-depth courses if difficulties with cases tempt
providers to return to less effective interaction with patients (Britt, Hudson, & Blampied,
2004; van Eijk-Hustings et al., 2011; Mesters, 2009). Preliminary evidence indicates that
medical staffs that complete such training can maintain empathy and therapeutic skills up
to six months after reviewing motivational interviewing one time (van Eijk-Hustings et
al., 2011).
Health behavior counselors' understanding of human development can also aid the
medical community in evaluating psychological profiles and the adaptability of
interventions in healthcare systems and services. Their expertise will allow them to
provide consultation on mental health issues as they pertain to treatment. For instance,
anxiety and cognitive deficits may moderately affect medication adherence (DiMatteo,
Lepper, & Croghan, 2000; Gonzales et al., 2008), but depression can dramatically reduce
adherence by 66% for many individuals (DiMatteo et al., 2000). Clinicians and
physicians, after brief psychoeducation by health behavior counselors, that note this
relationship in treatment can provide patients warm hand-offs to mental health
professionals. Referrals will afford individuals more holistic care with additional
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therapies, including counseling and psychotropic medications, so that their psychological
profiles sustain prolonged improvements in health behavior.
Similarly, health behavior counselors can apply the same aptitude for evaluation
to assess how well healthcare providers adapt to structural interventions aimed at
enhancing prescription drug use. Identifying which barriers to MA reoccur in inpatient or
outpatient settings is an important first step (DiMatteo et al., 2012). Needs assessment
often determines that medication adherence is subject to practical barriers, like
transportation and insurance coverage (DiMatteo, 2004), for example. In these cases,
healthcare providers that involve family support and community resources have a larger
system to combat these challenges (Newell, Bowman, & Cockburn, 2000); and,
moreover, continued successes with medication adherence due to this collaboration will
only reinforce patients' internal locus of control about managing chronic disease.
Finally, the growing trend toward evidence-based practice necessitates that health
behavior counselors acquire empirical data on interventions addressing psychological
constructs and adherence (Britt et al., 2004; van Eijk-Hustings et al., 2011; Mesters,
2009). There is overwhelming information indicating that cognitive-behavioral
techniques and motivational interviewing are effective in clinical trials with convenient
sampling of highly motivated groups. In addition, there is some evidence that both give
patients and providers better tools for managing chronic diseases in outpatient and
inpatient settings (van Eijk-Hustings et al., 2011; Payne 2012), yet there remains room
for health behavior counselors to standardize the interventions' essential components into
concise plans that others can replicate over time. Medication adherence research stands to
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benefit if future investigations evaluate best practices that incorporate the discussed
implications for theory and practice.
Limitations
The observed outcomes demonstrated that a number of psychological pathways
along with age can influence a person's medication adherence. Nonetheless, the standard
fit index for categorical data models, root mean square error of approximation (RMSEA),
exceeded the recommended 0.08 criterion. Subsequent attempts to rearrange parameter
effects of noninfluential psychological constructions around internal locus of control and
time perspective did not bring the RMSEA estimate to the recommended cutoff. Future
studies must determine the best possible arrangement for the total model.
The primary benefit of using the 4-item MMAS is that it quickly captures past
medication-taking behaviors, which can be the best predictor of future behavior
(DiMatteo et al., 2012; Turner, Weiner, Yang, & TenHave, 2004). Even still, the 4-item
MMAS has marginal internal consistency (α = .61), which compelled Morisky and
colleagues to generate a second inventory after the NIH collected the current data. The
results should be confirmed with other measures with more optimal psychometric
properties, including the 8-item MMAS (Morisky, Ang, Krousel-Wood, & Ward, 2008),
which has higher internal consistency (α = .83).
Another limitation is that the path analysis does not compare medication
adherence for people taking antihypertensives and antidiabetics. Rather, it treats both as
similar examples of health behaviors for chronic disease management. Other adherence
studies have recently provided several rationales for simultaneously investigating
hypertension and diabetes care (Broadbent et al, 2011; Mann et al., 2009; Schimittdiel et
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al., 2008). Most notably, individuals with both diagnoses initially take oral prescriptions
and experience few symptoms (Lau & Nau, 2004). Medications for these conditions
typically have delayed tangible health benefits, meaning that the advantages of adhering
on a daily basis accrue over time. Moreover, the results demonstrated statistical evidence
that individuals had similar behaviors for most antihypertensive and antidiabetic drug
use.
One last limitation highlights strengths and weaknesses of results derived from
community-based observational studies. Primarily, our findings contribute information
amid a growing need to improve medication adherence (DiMatteo et al., 2007; Pinto et
al., 2005). Similar efforts to collect data in community settings may decrease selfreporting bias and improve the validity of self-reported medication adherence, whereas
convenient recruitment at research hospitals often captures opinions of patients with more
resources and motivation to improve health (Hood, 2011; Patel & Taylor, 2002). Our
study demonstrates how insights from more diverse populations derive valuable
information about chronic disease management.
Nonetheless, one must interpret the results of categorical data modeling with
some caution. The nature of observational studies requires several additional steps,
namely replication studies and clinical trials, to say conclusively medication adherence
will improve based on tailoring treatment to patients’ psychological motivators. For
instance, health behavior counselors will benefit from future studies with larger sample
sizes diagnosed with a variety of chronic conditions. Any new knowledge, whether it
replicates or challenges the presented data models, will provide them additional
information on barriers to prescription drug use. Secondly, health professionals must
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determine the effectiveness of targeting time perspective and internal locus of control in
individual interventions to increase adherence. Future efforts to compare clinicians’
advice-giving versus cognitive-behavior techniques or motivational interviewing will
further incentivize more health systems to adopt health behavior counseling. Given
evidence that patients with hypertension or diabetes struggle with medication adherence,
another important step is implementing population-based randomized clinical trials to
verify the benefit of training and evaluation related to patient motivation to reduce
medical risks and costs across in-patient and outpatient settings.
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Appendix
List of Items om Medication Adherence, Time Perspective, Health Beliefs, and Health Locus of Control Beliefs
Variable
Medication adherence

Time perspective
Present-hedonistic

Item
1
2
3
4

Do you ever forget to take your medicine?
Are you careless at times about taking your medicine?
When you feel better do you sometimes stop taking your medicine?
Sometimes if you feel worse when you take the medicine, do you stop taking it?

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

I believe that getting together with one's friends to party is one of life's important pleasures.
I do things impulsively.
When listening to my favorite music, I often lose track of time.
I try to live my life as fully as possible, one day at a time.
Ideally, I would live each day as if it wre my last.
I make decisions on the spur of the moment.
It is important to put excitement in my life.
I feel that it is more important to enjoy what you are doing than to get work done on time.
Taking risks keeps my life from being boring.
It is more important to me to enjoy life's journey than to focus only on the destination.
I take risks to put excitement in my life.
I often follow my heart more than my head.
I find myself getting swept up in the excitement of the moment.
I prefer friends who are spontaneous rather than predictable.
I like my close relationships to be passionate.
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List of Items om Medication Adherence, Time Perspective, Health Beliefs, and Health Locus of Control Beliefs (Continued)
Variable

Item

Time perspective
Present-fatalistic
1
2
3
4
5
6
7
8
9

Fate determines much in my life.
Since whatever will be will be, it does not really matter what I do.
It takes joy out of the process and flow of my activities, if I have to think about goals, outcomes, and products.
You can't really plan for the future because things change so much.
My life path is controlled by forces I cannot influence.
It does not make sense to worry about the future, since there is nothing that I can do about it anyway.
Life is too complicated; I would prefer the simpler life of the past.
Spending what I earn on pleasures today is better than saving for tomorrow's security.
Often luck pays off better than hard work.

1
2
3
4
5
6
7
8
9
10
11
12
13

I believe that a person's day should be planned ahead each morning.
If things do not get done on time, I do not worry about it (reversed).
When I want to achieve something, I set goals and consider specific means for reaching those goals.
Meeting tomorrow's deadlines and doing other necessary work comes before tonight's play.
It upsets me to be late for appointments.
I meet my obligations to friends and authorities on time.
I take each day as it is rather than try to plan it out (reversed).
Before making a decision, I weigh the costs against the benefits.
I complete projects on time by making steady progress.
I make lists of things to do.
I am able to resist temptations when I know that there is work to be done.
I keep working at difficult, uninteresting tasks if they will get me ahead.
There will always be time to catch up on my work (reversed).

Future
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List of Items om Medication Adherence, Time Perspective, Health Beliefs, and Health Locus of Control Beliefs (Continued)
Variable
Health beliefs
Perception of disease severity
Perception of susceptibility
to future complications
Health locus of control beliefs
Internal locus of control

Item

1
1

Which of the following statements best describes your view of high blood pressure?
High blood pressure can increase a person’s risk of having stroke, heart trouble, or kidney failure in the future.
Which of the following statements best describes how you think about your high blood pressure?

1
2
3
4
5
6

If I get sick, it is my own behavior which determines how soon I get well again.
I am in control of my health.
When I get sick, I am to blame.
The main thing which affects my health is what I myself do.
If I take care of myself, I can avoid illness.
If I take the right actions, I can stay healthy.

1
2
3
4
5
6

No matter what I do, if I going to get sick, I will get sick.
Most things that affect my health happen to me by accident.
Luck plays a big part in determining how soon I will recover from an illness.
My good health is largely a matter of good fortune.
No matter what I do, I'm likely to get sick.
If it's meant to be, I will stay healthy.

1
2
3
4
5

Having regular contact with my physician is the best way for me to avoid illness.
Whenever I don't feel well, I should consult a medically trained professional.
My family has a lot to do with my becoming sick or staying healthy.
Health professions control my health.
Whenever I recover from an illness, it's usually because other people have (for example,
doctors, nurses, family, friends) have been taking good care of me.
Regarding my health, I can only do what my doctor tells me to do.

Chance

Powerful others

6
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